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Abstract
Introduction. Coronavirus Disease 2019 (COVID-19) poses a major global threat to human beings, which
has caused devastating consequences of population health, political, and economic crises in many
countries. This dissertation was composed of three research activities to study the following aims: (1)
review the existing literature focusing on political factors and health outcomes of COVID-19; (2) assess
the relationship between democracy and case fatality rate of COVID-19 by controlling for the effect of age,
comorbidity, health expenditure, healthcare workforce, and population density; and (3) identify the
trajectory pattern cases peak days, deaths peak days, and peak periods.
Methods. We accessed data from the World Health Organization (WHO), World Bank, Johns Hopkins
University, and the Democracy Index 2019 database. First, we conducted a systematic review that
searched three databases and synthesized the articles about democracy and health outcomes of
COVID-19. Second, we analyzed data from 148 countries with at least 2,000 confirmed cases of COVID-19
by October 25, 2020. Multiple linear regression was used to examine the association between the
Democracy Index and case fatality rate of COVID-19 while controlling for other variables, most notably the
age distribution of the population. Lastly, we used the patterns of data at the early onset of COVID-19
from seven countries to estimate the time lag between peak days of cases and deaths.
Results. Our first research found that of 170 publications in the databases search, 12 publications were
screened for systematic review. Among them, one study reported no association between democracy and
health outcomes of COVID-19. Eleven articles claimed there was a relationship between democracy level
and outcomes of COVID-19. Two papers reported negative associations between democracy and adverse
outcomes of the population, while the other nine articles claimed there were positive associations
between democracy and the poor health status of populations. When examining the relationship between
democracy and health outcomes of COVID-19, the second research demonstrated that the number of
hospital beds, the proportion of population above age 65, and current health expenditure as a percentage
of the gross domestic product (GDP) are significantly related to the case fatality rates of COVID-19 across
148 countries (p < 0.05). The Democracy Index was not statistically related to the case fatality rates of
COVID-19 when considering all 148 countries analyzed but was negatively associated with case fatality
rates among 47 high-income countries. In addition, the healthcare workforce, population density, and
comorbidity were not statistically significant among the 148 countries. Finally, the findings in the last
research suggested that comparative analyses of data from different regions and countries reveal the
differences between peaks of cases and deaths caused by COVID-19 and the incomplete and
underestimated cases in Wuhan. Different countries may show different patterns of cases peak days,
deaths peak days, and peak periods. Error in the early COVID-19 statistics in Brazil was identified.
Conclusions. This research is the first to our knowledge to study the relationship between democracy and
health outcomes of COVID-19 across countries with large sample sizes. According to the multicountry
data, the cross-sectional study suggests that enhancing healthcare system facilities is vital to improving
clinical outcomes. Protecting the population older than 65 and adjusting the health expenditure budget
may need to be considered. The findings suggest that in high-income countries the higher democracy
index is associated with more deaths from COVID-19, perhaps due to the decreased ability of the
government to control the movement and behavior of its citizens. Besides, the simulated graphical
trajectory method identifies statistical biases in surveillance data. This approach incorporates all sources
of available data and provides a robust method to characterize the time course of an infectious disease.
Regions and countries beginning with high mortality rates from the COVID-19 epidemic will suffer a long,
painful period of the disease epidemic. Where the mortality rate is relatively high, healthcare

professionals should prepare for a longer period of fighting this pandemic. Data quality is key to case
fatality rate estimation which is needed by policymakers to make correct and timely critical decisions.

Document Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Program
Health Outcomes and Policy Research

Research Advisor
J. Carolyn Graff, PhD

Keywords
Case fatality rate, COVID-19, Democracy, Healthcare system, Population

Subject Categories
Analytical, Diagnostic and Therapeutic Techniques and Equipment | Diseases | Epidemiology | Health and
Medical Administration | Health Services Administration | Health Services Research | Investigative
Techniques | Medicine and Health Sciences | Other Public Health | Public Health | Public Health Education
and Promotion | Virus Diseases

UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER
DOCTORAL DISSERTATION

Responding to the Pandemic: A Multicountry
Study on Social-Political Factors and Health
Outcomes of COVID-19

Author:
Lan Yao

Advisor:
J. Carolyn Graff, Ph.D.

A Dissertation Presented for The Graduate Studies Council of
The University of Tennessee Health Science Center
in Partial Fulfillment of the Requirements for the Doctor of Philosophy degree from
The University of Tennessee
in
Health Outcomes and Policy Research: Health Policy Track
College of Graduate Health Sciences

November 2021

Chapter 3 © 2021 by Springer Nature Switzerland AG.
All other material © 2021 by Lan Yao.
All rights reserved.

ii

DEDICATION

This dissertation is dedicated to
My wonderful parents who have raised me to be the person I am today,
My husband who believes in the richness of learning,
My daughter who makes me keen on progressing,
Myself who never expected to arrive at this milestone in my life.

iii

ACKNOWLEDGEMENTS

I would like to thank my mentor, Professor Joyce Carolyn Graff. Your mentorship
was invaluable in formulating the research questions and methodology. Your insightful
supervision and encouragement helped me to sharpen my thoughts and brought my work
to an advanced level. I also learned a lot from you and admire your personality,
intelligence and beautiful mind.
I would also thank my committee members, Dr. James E. Bailey, Dr. Scott C.
Howard, Dr. Minghui Li and Dr. Jim Y. Wan, for their constructive guidance throughout
my research. They provided me with the tools that I needed to choose the right direction
and successfully complete my dissertation research.
I would particularly like to single out Dr. Donald Thomason and Dr. Weikuan Gu
and acknowledge you for your support and contribution to the joint Ph.D. program.
To my family, I am forever grateful for your love, patience and understanding.
Without you believing in me, I never would have made it. It is time to celebrate, you
earned this degree right along with me. I have time now to reconnect with each of you.
I appreciate the scholarship and funding provided by University of Tennessee
Health Science Center to support me through the training.
Last, thank you to the countless healthcare professionals worldwide who are
selflessly saving, curing, and protecting humankind during the COVID-19 pandemic.

iv

ABSTRACT

Introduction. Coronavirus Disease 2019 (COVID-19) poses a major global threat to
human beings, which has caused devastating consequences of population health, political,
and economic crises in many countries. This dissertation was composed of three research
activities to study the following aims: (1) review the existing literature focusing on
political factors and health outcomes of COVID-19; (2) assess the relationship between
democracy and case fatality rate of COVID-19 by controlling for the effect of age,
comorbidity, health expenditure, healthcare workforce, and population density; and (3)
identify the trajectory pattern cases peak days, deaths peak days, and peak periods.
Methods. We accessed data from the World Health Organization (WHO), World Bank,
Johns Hopkins University, and the Democracy Index 2019 database. First, we conducted
a systematic review that searched three databases and synthesized the articles about
democracy and health outcomes of COVID-19. Second, we analyzed data from 148
countries with at least 2,000 confirmed cases of COVID-19 by October 25, 2020.
Multiple linear regression was used to examine the association between the Democracy
Index and case fatality rate of COVID-19 while controlling for other variables, most
notably the age distribution of the population. Lastly, we used the patterns of data at the
early onset of COVID-19 from seven countries to estimate the time lag between peak
days of cases and deaths.
Results. Our first research found that of 170 publications in the databases search, 12
publications were screened for systematic review. Among them, one study reported no
association between democracy and health outcomes of COVID-19. Eleven articles
claimed there was a relationship between democracy level and outcomes of COVID-19.
Two papers reported negative associations between democracy and adverse outcomes of
the population, while the other nine articles claimed there were positive associations
between democracy and the poor health status of populations. When examining the
relationship between democracy and health outcomes of COVID-19, the second research
demonstrated that the number of hospital beds, the proportion of population above age
65, and current health expenditure as a percentage of the gross domestic product (GDP)
are significantly related to the case fatality rates of COVID-19 across 148 countries (p <
0.05). The Democracy Index was not statistically related to the case fatality rates of
COVID-19 when considering all 148 countries analyzed but was negatively associated
with case fatality rates among 47 high-income countries. In addition, the healthcare
workforce, population density, and comorbidity were not statistically significant among
the 148 countries. Finally, the findings in the last research suggested that comparative
analyses of data from different regions and countries reveal the differences between
peaks of cases and deaths caused by COVID-19 and the incomplete and underestimated
cases in Wuhan. Different countries may show different patterns of cases peak days,
deaths peak days, and peak periods. Error in the early COVID-19 statistics in Brazil was
identified.
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Conclusions. This research is the first to our knowledge to study the relationship between
democracy and health outcomes of COVID-19 across countries with large sample sizes.
According to the multicountry data, the cross-sectional study suggests that enhancing
healthcare system facilities is vital to improving clinical outcomes. Protecting the
population older than 65 and adjusting the health expenditure budget may need to be
considered. The findings suggest that in high-income countries the higher democracy
index is associated with more deaths from COVID-19, perhaps due to the decreased
ability of the government to control the movement and behavior of its citizens. Besides,
the simulated graphical trajectory method identifies statistical biases in surveillance data.
This approach incorporates all sources of available data and provides a robust method to
characterize the time course of an infectious disease. Regions and countries beginning
with high mortality rates from the COVID-19 epidemic will suffer a long, painful period
of the disease epidemic. Where the mortality rate is relatively high, healthcare
professionals should prepare for a longer period of fighting this pandemic. Data quality is
key to case fatality rate estimation which is needed by policymakers to make correct and
timely critical decisions.
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CHAPTER 1.

INTRODUCTION

Social-Political Factors and Health Outcomes
Research on the determinants of health has crossed the conventional scope of the
health care system and the public health domain. Income level, housing, food security
and nutrition, education, and community security also play an important role in health
promotion.1 What’s more, in recent years, there has been a large number of published
studies that look at health issues through the lens of social-political factors and describe
the associations between social-political factors and health outcomes. Beckfield and
Krieger argue that one section of epidemiological research calls for greater exposure to
the social structures, networks, and fundamental social features, e.g., socioeconomic
status, race, and gender, used to assess health outcomes. On the other hand, another
section concentrating on the political economy of health focuses on how various types of
policy institutionalizations, political processes, and organizations influence the wellbeing of the community. The authors also bring up the agenda that new exploration
which consolidates the qualities of political science and social science studies of disease
transmission is attainable, hypothetically important, and strategically applicable.2
Empirical studies have been conducted using longitudinal data that include political
factors as major predictors. For example, Navarro et al. investigated the relationship
between political ideology and health outcomes based on data from high-income
countries. The authors conclude that political ideologies are related to some aspects of
health outcomes.3,4
What we know about the association between political factors and health
outcomes is mainly based on observational studies. However, the research that
concentrates on political features and health outcomes repeatedly selects life expectancy,
maternal mortality, and infant mortality as the outcomes to examine the potential
correlation. Additionally, empirical investigations have focused on the correlation
between political factors and life expectancy across countries with large sample sizes. For
instance, Franco et al. examined the impact of democracy in 75% of the countries and
territories around the world on life expectancy, maternal mortality, and infant mortality,
taking into account the country’s wealth, social justice, and the share of public sector
investment. The authors suggest that health metrics demonstrate a statistically important
association with the degree of democracy: the highest rates of healthcare capacity are in
democratic countries, followed by partially democratic countries. The lowest levels of
health care capacity are in authoritarian countries. After adjusting for income level, social
inequality, and the total government expenditure (size of the public sector), a positive
association between health and democracy remained. Therefore, political factors are
variables that appear to be related to the health outcomes of a given population.5 Besley
and Kudamatsu used longitudinal datasets collected from different countries to
investigate the connection between democracy and health status. Their research reveals
that life expectancy has been strongly associated with democracy.6 Similarly, Bollyky et
al. implemented significant analysis and discussion on democracy and cause-specific
mortality. These authors employed a dataset of 170 countries for 46 years to examine the
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relationship between democracy and population health. Life expectancy, cause-specific
mortality, and democratization are correlated. The longer life expectancy is positively
related to a higher level of democracy.7 In another empirical study, Lake and Baum report
that, across the world, democracy has an optimistic and substantive effect on citizens’
daily life and well-being.8 However, we should notice that health outcome is also
associated with national wealth and total health care expenditures.9 Thus, the connection
between political factors and health outcomes is confounded by a country’s income level
so that some existing research suffers from these confounding factors that modify the
effect of an independent variable. Besides, data are more likely to be missing in lowincome countries which may lead to data being subject to bias and not representative.
The generalizability of the research discussed above is also problematic because
the health outcomes studied only involve life expectancy, maternal mortality, and infant
mortality; therefore, the correlation between political factors and health outcomes needs
to be interpreted with caution. To date, few inquirers have been able to perform datadriven research to examine the effect of political factors on infectious disease outcomes.
In an analysis of the HIV/AIDS disease, Gizelis has methodologically broken down how
political features and public health strategies may help curb the spreading of AIDS and
demonstrates that countries with more stringent regulations are more likely to mitigate
the transmission of HIV/AIDS. Furthermore, the author contends that governments of
solid dictatorships can execute effective measures with fewer requirements and are more
proficient in controlling the infection of HIV/AIDS.10 Taking a theoretical perspective to
examine the mitigation of SARS, Fidler has insisted that SARS was a novel pathogen for
which there were no effective pharmaceuticals for treatment, vaccination, and therapy.
For many countries, containing SARS depends on social distancing, isolation and
quarantine, raising questions regarding measures necessary to protect the health of the
community or population while upholding human rights.11
Studies have also demonstrated the impact of social-political factors on COVID19 since the outbreak. In an investigation into the current COVID-19 pandemic, Badr et
al. argue that social distancing played an essential role in reducing the new cases between
March and April in many American counties. This is based on their statistical analysis
which showed a correlation between the patterns of human mobility and the decreasing
transmission rate of COVID-19 in the United States, with Pearson correlation rates above
0.7 for 20 of 25 counties.12 What’s more, Burkle and Devereaux claim that public health
policy and regulations have been affected significantly by political pressure. The results
of urgent healthcare management decision-making are important in determining the
likelihood of health care effectiveness, the control of the epidemic, and the conservation
of scarce resources.13 Edelman et al. discussed what they have observed and learned from
the HIV/AIDS epidemic worldwide to inform the response to the COVID-19 pandemic.
They emphasize that, unlike HIV/AIDS, a political misunderstanding of COVID-19
contributes to a strategic reaction that will be insufficient and awkward.14 Frey et al.
found that autocratic regimes impose stricter lockdowns and rely more on contact
traceability, along with real-time data that includes daily data about citizens’ travel and
movement in 111 countries. Even though autocracies have introduced stricter lockdowns
and more contact tracing, democracies have been more successful in achieving the policy
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goal of reducing domestic mobility in their countries.15 A follow-up study on this subject,
Greer et al. claim that there will be no way to explain the various responses and results of
COVID-19 without understanding politics and policy. They continue to argue that a
research agenda to address the COVID-19 pandemic that focuses on political factors will
improve the implementation of feasible and effective policies and broaden our understanding of public health policy dealing with emerging and re-emerging pandemics.16
Similarly, Kavanagh et al. discuss important issues posed in the context of the COVID-19
pandemic about how we think about the interactions among government, population, and
public health policy. The authors believe that the gap between countries on these aspects
specifically defines how public health accountability can and should be integrated as
authoritarian regimes have won compliments for their response while major democracies
have wrestled to respond.17,18 These studies highlight the importance of assessing the role
of social-political factors on COVID-19 outcomes and discover the pathways of these
factors in determining the health outcomes of the population during the pandemic.

Statement of the Problem
COVID-19 poses a major global threat to human beings, causing devastating
consequences from population health, political, and economic crises in many countries.16
The World Health Organization (WHO) announced that the novel Coronavirus Disease
2019 (COVID-19) outbreak was a public health emergency of international concern on
January 30, 2020.19 On March 11, 2020, the COVID-19 outbreak officially became a
pandemic,20 subsequently causing 191,686,787 confirmed cases and 4,112,533 deaths
worldwide as of July 20, 2021.21 The number of infections (as of July 20, 2021) are
23,677 times more than the infections that occurred during the previous outbreak of
severe acute respiratory syndrome (SARS) from 2002 to 2003.11 Furthermore, according
to the COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE)
at Johns Hopkins University, the data show that the total numbers of confirmed cases and
deaths related to COVID-19 vary dramatically across countries, which cannot be
adequately explained because the pandemic started earlier in some countries than in other
countries.22
Although empirical investigations are illustrating the associations between the
public health policy, healthcare, social-economic characteristics, and health outcomes of
COVID-19, it is critical to inquire if the social-political factors are related to morbidity
and mortality rates of COVID-19 worldwide.23-25 Therefore, identifying contributing
factors that are not fully understood in previous research but potentially impact health
outcomes during a global pandemic is necessary.

Philosophical and Theoretical Frameworks
The paradigm of this quantitative research is based on postpositivism.
Postpositivism is a metatheoretical stance that critiques and amends positivism and has
impacted theories and practices across philosophy, social sciences, and various models of
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scientific research. While positivists emphasize independence between the researcher and
the participant or sample, postpositivists argue that the researcher’s theories, hypotheses,
background knowledge, and values can influence what is observed.26 Postpositivists
pursue objectivity by recognizing the possible effects of biases.27,28
Theories are framed to interpret, foresee, and understand a phenomenon and to
test and accumulate existing knowledge within the ranges of assumptions. The theoretical
framework is the structure that can hold or support a theory of a research study. The
theoretical frameworks describe the mechanisms that explain the associations between
social-political factors and health outcomes. Postpositivists believe that theory,
hypothesis, knowledge, and worldview of the researcher can affect what is observed.
Postpositivists pursue objectivity by recognizing the possible effects of biases.26 This
dissertation research utilizes the following theoretical frameworks to inform the study,
i.e., political epidemiology, social epidemiology, and the social-ecological model.

Political epidemiology
Political epidemiology theory developed by Arthur Brownlea demonstrates that
politics play a role in solving health problems and health crisis mitigation as significant
as medical treatment and epidemiological strategies. Figure 1-1 displays the dimensions
of the political epidemiologic process. Humankind first recognizes a health problem; in
the next step, they deal with the information, adopt the value positions and then make
political decisions; eventually, their interpretation and judgment will lead to certain
evaluation and further social choices and problem recognition (Figure 1-1).29

Social epidemiology
Social epidemiology firstly obtained its name in the 1950s. Social epidemiology is
a division of epidemiology that concentrates primarily on the effects of social-structural
predictors on the status of well-being. Social epidemiology proposes that social class
influences the distribution of disease and health. The theory assumes to identify societal
features that influence the natural history of disease and health outcomes in society and to
capture its mechanisms.30 Social epidemiology intends to address the questions of what
effects social predictors have on individual-level and population-level health. The
solutions will clarify the relationship between health outcomes and social-political
infrastructures.31

Social-ecological model
The social-ecological model was created to have an in-depth understanding of the
interactive associations among individual and social-ecological factors. The social-
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Figure 1-1.

Political epidemiology process

Reprinted from Social Science & Medicine, Part D: Medical Geography 15, no. 1,
Brownlea, Arthur, From Public Health to Political Epidemiology, 57-67, (1981), with
permission from Elsevier.29
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ecological model was brought into use as a response to the scope of research directed by
psychologists.32 The model points out that one factor exerts an effect on another. The
essence of the social-ecological model is that an event influences another event, and each
event presented is related to the dynamic circumstances while adjusting to the
environment within which it exists. The five hierarchical levels are influenced by factors
including not only gene expression but also the political systems. It is impossible to
thoroughly perceive the meaning of the whole picture if researchers do not consider how
these components impact and transform each other. When the elements communicate and
interact, they realize the function and features of society.33,34

Research Aims and Questions
Our research addressed a set of questions with respect to the COVID-19
pandemic. The aims and questions were designed (1) to conduct a systematic review on
the literature about political factors and health outcomes; (2) to examine the relationships
between social-political factors and health outcomes of COVID-19; (3) to reveal the
biases of cases and deaths of COVID-19 in terms of data collection problems:
Aim 1. First, we aimed to explore and evaluate the collective evidence in political
factors and health outcomes and then investigate the relationship between
political factors and health outcomes of COVID-19, with particular
emphasis on identifying gaps in this field.
Question 1: Does democracy affect the health of a population?
Question 2: What is the relationship between democracy and health
outcomes of COVID-19?
Aim 2. Second, we intended to examine the relationships between the Democracy
Index and the case fatality rate of COVID-19 across countries. In addition, it
also examined other factors, such as population density, comorbidity, and
healthcare expenditures, which may be correlated with the case fatality rate
of COVID-19.
Question 1: What is the relationship between the Democracy Index and the
case fatality rate of COVID-19?
Question 2: What are the relationships between the Democracy Index and
the case fatality rate of COVID-19 taking into account the
covariates?
Aim 3. Last, we investigated the information biases of cases and deaths reporting of
COVID-19 in terms of data collection problems.
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Question 1: What are the differences and similarities in the reporting of
COVID-19 cases and deaths among sampled countries?

Significance of the Study
Identifying the predictors of COVID-19 related outcomes is very important for
improving the health of the population worldwide when there is no approved
pharmaceutical treatment and therapy during a pandemic. Currently, the role of socialpolitical factors on COVID-19 has not been thoroughly understood. This research helps
identify the factors that impact the transmission rate and health outcomes of the COVID19 pandemic. This study is not only of great theoretical importance but is also beneficial
to policymakers, leaders, and the population worldwide.

Theoretical contribution
The existing theories and literature lay a foundation for research that examines
how social determinants and healthcare affect humankind’s health. However, socialpolitical factors have always been treated as minor predictors of human well-being. This
three-essay research study contributes to the growing body of knowledge that strengthens
the theories and equips researchers and stakeholders to understand how social-political
features affect the health outcomes of populations during an unprecedented health crisis.
Additionally, this research suggests a graphical trajectory method to identify and examine
biases resulting from the data collection at the initial phase of the epidemic. It also
presents a new perspective for future work that would explore the attributes which are
associated with quality of life, such as post-pandemic trauma and mental health
consequences as well as morbidity and mortality of emerging/re-emerging communicable
diseases worldwide.

Policymakers
Several groups of stakeholders may benefit from this study focusing on the
association between social-political factors and health outcomes. Utilizing the findings
from this study, policymakers can leverage the evidence-based results to establish
specific public health policy about pandemic control under the circumstances both in
terms of scarce resources and in terms of urgent decision-making. The findings could
inform policymakers to propose health policies that will enhance a population's health
status. Furthermore, policymakers can effectively disseminate the research findings in
white papers to bridge the gaps between knowledge, a health policy proposal, and policy
application.35
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Leaders
By understanding that social-political factors influence the health of a population,
the government leaders could more easily understand the need to make changes, improve,
or reform their current policy. On the one hand, the results could assist leaders to
recognize dynamic contexts, comprehensively integrate the interests of the individual and
society, and enhance the accountability of leadership. On the other hand, an effective
health policy would strengthen the political capital and governance capacity. This
research represents an important step towards understanding the critical relationships
among leaders, government, and health outcomes of a population.36

Population
This empirical study highlights the connection between social-political factors
and health outcomes to effectively contain the COVID-19 pandemic. The population
worldwide would benefit from the research findings, which optimize health policy and
thus promote the health of a population. What’s more, the unprecedented crises
threatening people all over the world for two years would be addressed and possibly
eliminated or allow a return to normal as the pandemic comes under control.

Limitations
The findings of this study must be seen in the light of four limitations. First, due
to the self-reported data collected from different countries, the open-use datasets retrieved
from international institutions and organizations may have heterogeneity of
measurements across countries. Second, the confirmed cases of COVID-19 are likely to
be underestimated because of the capacity of COVID-19 testing and scarcity of medical
resources within some low-income or middle-income countries. For example, the PCR
testing kits will likely limit the numerator of the morbidity rate calculation.37 Conversely,
the deaths of COVID-19 are likely to be overestimated because of excess deaths and
death certificate coding.38 Third, data collected for the original research purpose may not
be able to respond to all research questions within this dissertation research. Finally, the
causal relationships of social-political factors and health outcomes of COVID-19 cannot
be assumed and tested due to the limited period of study. However, we encourage future
work to leverage retrospective research designed to accomplish the goal of answering
questions that cannot be addressed in this study.

Definition of Terms
This three-essay dissertation involves a series of well-established concepts used in
the fields of public health, social science, economics, and ecology. The following terms
clearly define the scope and meaning illustrated in this dissertation.
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Case fatality rate: “the proportion of people who die from a specified disease
among all individuals diagnosed with the disease over a certain period of time”.39
COVID-19: “a respiratory disease caused by SARS-CoV-2, a new coronavirus
discovered in 2019. The virus is thought to spread mainly from person to person through
respiratory droplets produced when an infected person coughs, sneezes, or talks”.40
Democracy: “a system of governance in which rulers are held accountable for
their actions in the public realm by citizens, acting indirectly through the competition and
cooperation of their elected representatives”.41
Democracy Index: “an index compiled by the Economist Intelligence Unit (EIU),
the research division of the Economist Group, a UK-based private company which
publishes the weekly newspaper The Economist. The index is self-described as intending
to measure the state of democracy in 167 countries, of which 166 are sovereign states and
164 are UN member states”.42
Health: The current widely used definition of health is offered by World Health
Organization (WHO). Health is a state of physical, mental, and social well-being and the
absence of disease.43
Health expenditure: Health expenditure is the amount of money spent for health
and healthcare service by citizens and the public sector out of total income.44
Health outcomes: The result of a medical status that directly influences the life
expectancy or quality of life.45
Health policy: Health policy is defined as policies, strategies, and
implementations made to achieve particular health care outcomes in society. There is a
range of items that can be accomplished by a clear health policy. It establishes an
orientation for future work and provides evidence for the current program. It points out
the priorities and expected behavior of society.46
Morbidity: The percentage of people who have complications from a medical
condition or after a procedure or treatment.39
Mortality: Alternatively used as death rate, is a measure of the number of deaths
(in general, or due to a specific cause) in a particular population, scaled to the size of that
population, per unit of time.39
Population health: Population health is defined as the health outcomes of a group
of individuals as well as the distribution of health outcomes in this group.47
Social determinants of health: Social determinants of health are factors that are
associated with the environment where people reside, study, entertain, and work that
exert an effect on the health outcomes and quality of life.48
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CHAPTER 2.

THE EFFECT OF DEMOCRACY ON HEALTH OUTCOMES IN
COVID-19: A SYSTEMATIC REVIEW

Introduction
COVID-19 has lasted for about two years and likely will go on spreading. The
pandemic triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has threatened humankind and healthcare systems in the global community. The viral
transmission has been complicated not only by the existence of asymptomatic individuals
but also by the constrained supply of testing kits, ICU beds, and healthcare workforce and
more recently the transmissible Delta variant.49,50 The overloaded hospitals and
tremendous loss of lives urge researchers to thoroughly capture the factors associated
with morbidity and mortality of COVID-19. Most existing systematic reviews focus on
the epidemiological characteristics of the novel virus, prediction models for diagnosis and
prognosis of patients, and the effectiveness of mitigation measures.51-53 However, there is
a lack of in-depth understanding of the fundamental factors that could explain the
variations of outcomes across countries. When a re-emerging communicable disease
turns into a global pandemic, synthesizing valid evidence to inform policymakers and
healthcare professionals is vital for pandemic containment. In such an urgent context, the
World Health Organization (WHO) suggests rapid reviews for relevant evidence to
support public health policy and healthcare systems.54 Therefore, we synthesize the
existing literature to review the political factors specifically, democracy, which may be
correlated with the health outcomes of COVID-19.
We conducted a narrative systematic review of the existing literature to identify
whether democracy had been reported in empirical studies on COVID-19 and then
assessed the associations between democracy and health outcomes, including cases or
deaths per capita, case fatality rate (CFR), and mortality. To overcome the lack of a
reliable background about the relationship between political factors and health outcomes
of COVID-19, this systematic review will not limit itself by simply investigating studies
that have linked democracy level and adverse outcomes. In addition, it also appraised
literature that had investigated the indirect measurements that may affect COVID-related
health outcomes.

Methods
This systematic review was conducted aligned with PRISMA guidelines
(Appendix A).55 We searched PubMed, EMBASE, and MEDLINE databases. The
author (LY) designed the systematic review protocol and discussed it with coauthors
(JCG and MHL) for modification. We used a combination of keywords, COVID-19,
coronavirus, and democracy. Research articles in the English language, published from
January 1, 2020, to August 16, 2021, were included. We also excluded comments,
reviews, and personal perspectives. The Joanna Briggs Institute Critical Appraisal
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Checklist for studies reporting prevalence data was employed to evaluate the
methodological quality of the selected articles(Appendix B).56
We comprehensively screened the title and abstract for each included article and
reviewed the included studies that reported democracy and COVID-19 related outcomes.
Articles that did not utilize empirical data or theoretical proposals were excluded. In the
next step, we appraised the full-text papers in terms of sample size (or participants),
outcomes of interests, covariates, methods, and findings to extract relevant data on
whether or not democracy was addressed and its association with outcomes of COVID19.
Two independent authors (LY and JCG) reviewed the title and abstract for each
article that met inclusion criteria and completed the full-text reviews. Quality assessment
was carried out by LY and JCG. LY performed the database search on PubMed,
EMBASE, and MEDLINE. We used an intelligent systematic review software Rayyan
for article screening and collaboration between researchers. Disagreements on inclusions
or exclusions were resolved through team discussions. The review team approved the
final systematic review inclusions.

Results
A total of 296 articles published between January 1, 2020, to August 16, 2021,
were identified from three electronic databases. In total, 126 papers were excluded since
they were duplicates. Of the remaining 170 articles, 104 articles were published in 2020
and 66 articles in 2021. Seventy-seven articles were excluded because of irrelevant
outcomes of the research. Meanwhile, we also excluded 74 articles due to wrong
publication types, such as comments, reviews, and personal perspectives. Seven articles
were excluded due to case study design and small sample size. Finally, 12 articles were
selected for further review and data extraction (Figure 2-1).
We found a trend toward increasing empirical studies examining the associations
between democracy and health outcomes of COVID-19. Data extractions are shown in
Table 2-1. All the articles were scored as high-quality research papers (Table 2-2).

Democracy as a concern
We identified 170 articles from the database search. Nine articles were published
in the journal Nature, two papers were published in JAMA, and two articles in BMJ. Of
the 170 included articles, 12 surveys and four cross-sectional studies were found.
Examining the included literature, we found 19 articles that reported concerns about
democracy and COVID-19.Seven articles were excluded due to case study design and
small sample size. Of these final 12 articles, seven investigated the relationship between
democracy level and case fatality rate, mortality, and cases or deaths per capita as
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Figure 2-1.

Systematic review flow chart
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Table 2-1.

Data extraction for selected articles

Source
Annaka
Susumu
2021
Japan

Study design
Crosssectional

Sample size
108

Outcomes
Deaths per
1,000,000

Predictors
Political regime;
Data transparency;
Government
Effectiveness;
Gross Domestic
Product(GDP) per
capita

Conclusions
The findings of the article suggest that political regime predictors are
not related with the counts of deaths and cases after controlling for
other factors, like data transparency. However, data transparency is
positively associated with the deaths and cases numbers.

Huang et al.
2020
Hongkong

Retrospective

94

Incidence of
COVID-19 per
100,000

COVID-19 Risk
Index;
Testing Policies;
Democracy Index;
Scientific Citation
Index;
GDP;
Human
Development
Index (HDI)

Countries did not experienced SARS or MERS epidemics were more
likely to have higher incidence of COVID-19.Full democracy countries
had higher incidence of COVID-19.Data indicated that a country’
performance to tackle with COVID-19 is correlated with its former
exposure to an epidemics and Democracy Index.

Jardine et al.
2020
Muslim

Retrospective

44

Cases per
1,000,000

Governance
systems;
Rapidity of
institution of
mitigation

Functional democratic regimes take much longer time of doubling cases
from COVID-19 than non-democratic ones among Muslim-majority
countries. Findings indicated that functional democracies were more
capable to mitigate the epidemic than non-democratic regimes.

Jinjarak et al.
2020
US

Retrospective

36

Mortality rate

Proportion of the
elderly population;
Proportion of
urban population;
Democratic
freedoms

Democratic countries are slower to reach their peak mortalities. The
results suggest that public health measures can reduce the mortality
growth, the peak mortality, and the duration to the first peak.
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Table 2-1.

(Continued)

Source
Karabulut et
al. 2021
Turkey

Study design
Retrospective

Sample size
128

Outcomes
Infection rate; Case
fatality rate

Predictors
Total Democracy Score;
Polity’s Democracy Index;
Electoral Democracy Index of the VDem Institute;
Gini coefficient;
tourism revenue per capita

Conclusions
Democracy level is significantly positively
related to infection rate. However, all
democracy indices are negatively associated
with the case fatality rate. Researchers
concluded that COVID-19 had less effect on
mortality for most democratic countries.

Mazzucchelli
et al.
2020
Spain

Retrospective

27

Mortality rate

Democracy index
Country's political system
Country's corruption index

Democracy index, the political system, and
the corruption index were statistically
associated with mortality. From west to east
Europe, the mortality of Covid-19 declined.
Mortality variability can be partly explained
by political factors.

Naeim et al.
2021
US

Crosssectional

125,508
Participants

COVID-19-related
concerns;
precautionary
behaviors; willingness
to return to activity.

Age; gender; race; education;
household income; political party
support; religion; news consumption;
number of medication prescriptions;
perceived COVID-19 status; timing
of peak COVID-19 infections by
state

Republicans compares to Democrats have less
COVID-19-related concerns, unwilling to
adopt the precautionary behaviors and prefer
to return to activity. Therefore, participants’
party affiliation was strongly associated with
COVID-19–related perceptions, precautionary
behaviors and activity.

Pak et al.
2021
Australia

Retrospective

102,627
Participants

Compliance
with government
restrictions and public
health guidelines

COVID-19 attitudes; behavioral
measures; COVID-19 government
response policies; measures of the
strictness of restrictions on people’s
behavior

Among political regimes, public trust is
positively related to the compliance of public
health measures. This study points out the
significance of public trust in government
during the COVID-19 pandemic.
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Table 2-1.

(Continued)

Source
Rocco et al.
2021
US

Study design
Retrospective

Sample size
15

Outcomes
Subnational data quality

Predictors
State capacity ;the
decentralization of resources and
authority; the quality of
democratic institutions

Conclusions
Data showed the variations of COVID-19
mortality, testing capacity and
hospitalization. COVID-19 data quality
depends on the level of democracy.

Sebhatu et al.
2020
Sweden

Retrospective

36

Daily counts of the
infected people; number
of deaths; speed of
adoption of the different
COVID-19 policies

Oxford COVID-19 Government
Response Tracker (OxCGRT);the
Varieties of Democracy (V-Dem)
database

Countries with a lower democracy level
were relatively faster to implement
COVID-19 measures. Democratic
countries are slower to respond in the
pandemic.

Sorci et al.
2020
France

Retrospective

72

Case fatality rate

Disability-adjusted life years
(DALYs); share of total disease
burden; age-standardized death
rates per 100,000; share of
deaths; Polity IV

Case fatality rate was positively related
with the level of democracy. These
results highlight the role of political
factors as possible predictors of
COVID‑19 case fatality rate.

Vadlamannati
et al.
2021
Norway

Crosssectional

210

Deaths per 1,000,000

V-Dem democracy index
Infant mortality rate;
Global Burden of Disease;
health access and quality index

Democratic governance shows the
opposite effect on fighting COVID-19
when health equity is concerned. Disease
control might rely on the health system
capacity rather than the societal factors.
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Table 2-2.

JBI critical appraisal results
Citation
Q1
Q2
Q3
Q4
Q5
Q6
Q7
Q8
Q9
Annaka. 2021
Y
Y
Y
Y
Y
Y
Y
Y
Y
Huang et al. 2020
Y
Y
Y
Y
Y
Y
U
Y
Y
Jardine et al. 2020
Y
Y
Y
Y
Y
Y
Y
Y
Y
Jinjarak et al.2020
Y
Y
Y
U
Y
Y
Y
Y
Y
Karabulut et al. 2021
Y
Y
N
Y
Y
Y
Y
Y
Y
Mazzucchelli et al. 2020
Y
N
N
Y
Y
Y
Y
Y
Y
Naeim et al. 2021
Y
Y
N
N
Y
Y
N
Y
Y
Pak et al.2021
Y
U
Y
Y
Y
Y
Y
Y
Y
Rocco et al. 2021
Y
Y
N
Y
Y
Y
Y
Y
Y
Sebhatu et al. 2020
Y
Y
Y
Y
Y
Y
Y
Y
Y
Sorci et al. 2020
Y
Y
Y
Y
Y
Y
Y
Y
Y
Vadlamannati et al. 2021
Y
Y
Y
Y
Y
Y
Y
Y
Y
Appraisal grade(%)
100.0 82.32 71.33 90.9 100.0 100.0 90.9 100.0 100.0
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dependent variables. We also found that the publications mainly originated in the US and
Europe.

Democracy and incidence
One retrospective study from Hong Kong published in August 2020 reported an
investigation of democracy and cases per million population in 94 countries. Their
findings suggest that a higher democracy level is associated with more incidences of
COVID-19.57 However, another paper argued that there is a negative association between
democracy level and cases per million population in Muslim-majority countries published
in October 2020. Cases in authoritarian Muslim-majority countries increased much faster
than democratic counterparts, 33.9 days versus 66.5 days for cases doubling.58
Democracy was not an independent predictor of health outcomes of COVID-19.
One article found that governments in democratic countries are slower to contain the
pandemic.59 The other two articles had reported survey data about COVID-19 related
concerns and behavior.60,61 One article published in the Journal of Health Politics found
the association between subnational surveillance data quality and the quality of
democracy.62

Democracy and mortality
Three articles published in SSM-Population Health, Scandinavian Journal of
Public Health, and Revista Espanola de Salud Publica found the association between
democracy and mortality. All three studies suggested that democratic countries are slower
to respond to pandemics and experience higher deaths per capita and mortality rates
compared to their authoritarian countries.63-65

Democracy and case fatality rate
One study found that there is a negative relationship between the democracy
measures and case fatality rates in 128 countries.66 However, a study of 72 countries
argued that case fatality rates are positively associated with democracy level.67

Discussion
We conducted a comprehensive search of the existing publications to identify
whether democracy had been reported in studies of COVID-19 as well as the association
between democracy and the health outcomes of COVID-19. We found that most of the
empirical research articles on political factors and the pandemic have been published
since 2021. This may be partially because of the gradual transmission of the virus across
countries, and researchers in different countries, observing the variations of the health
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outcomes, began to consider the political factors as predictors. Most retrospective studies
on democracy were based on data collected from Europe, where democracy is highly
valued among the citizens. All the included studies were high-quality articles in terms of
sample size, target populations, methodology, data analysis and response rate. The JBI
Critical Appraisal ratings reflected the extent of our confidence that the estimates of the
association were adequate to support a conclusion.
Further research is very unlikely to change the estimates of effect. In addition,
European countries also experienced high morbidity and mortality of COVID-19
according to cross-country surveillance. These can explain why a majority of articles on
this topic were published about European countries.
We found that peer-reviewed studies suggest that democratic countries may be at
higher risk of COVID-19 attack than authoritarian countries. However, we cannot find
any published evidence of an association between democracy and clinical health records;
this may reflect the small number of studies focusing on this problem.
Understanding the role of democracy in a pandemic has important implications
for public health policy. Even though existing literature suggests an association between
democracy and adverse outcomes from COVID-19, other risk factors may also contribute
to the higher risk of COVID-19 related infections and deaths in democratic countries.68
Early reports from the UK and Canada identified mobility as an important factor
for outcomes from COVID-19. Researchers examining big data collected from over 3
million mobile phone users between February 1, 2020, to May 16, 2020, revealed that
regional shutdowns during the COVID-19 epidemic reduced the total morbidity and
mortality.69 Similarly, an international comparative study used mobility tracing data
retrieved from ten countries to examine the linkage between mobility patterns, COVID19 transmission, and mortality rates across countries where different policies were
deployed.70 Other studies found that slow responding countries suffered more deaths per
100,000 population and had to execute more stringent measures when compared to early
responding countries. The results of these publications provide extremely meaningful
evidence in helping countries better manage a predictable wave of COVID-19 or any
other transmissible diseases.71
An explanation for the relationship between mobility and outcomes of COVID-19
is the transmission patterns.72 Researchers found a positive association between mobility
flow and the infected population during the COVID-19 onset in US counties from March
1 to June 9, 2020.73 Citizens’ mobility may not be limited in some democratic countries,
resulting in a higher risk of viral transmission and consequently increasing confirmed
cases.74 The stringent lockdown and quarantine measures are common for authoritarian
countries in Asia but implemented less in the European and the American continents.75
Individuals living in authoritarian countries might be likely to comply the public health
strategies, protecting themselves from fatal disease.76 However, the interactions between
democracy, individual behavior, and outcomes of COVID-19 remain unclear.
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A handful of fatal infectious diseases claim millions of lives worldwide each
year. People in different countries become ill and die from a variety of infectious
diseases, resulting from different responses among these populations.78 Citizens from
democratic or authoritarian countries have specific behavior, interpersonal trust, and
social profiles, which affect their responses to the pandemic.79 Therefore, individuals
from different levels of democracy may have varying concerns and attitudes on COVID19.80 For instance, a cross-national Facebook survey indicates significant heterogeneity in
threat perceptions.81 Historically, countries with more serious legitimate regulations were
more likely to mitigate the transmission of the Human Immunodeficiency Virus (HIV).
Authoritarian countries can execute effective approaches with fewer requirements.
Democratic political systems will be progressively accessible to the necessities of the
population and can be fundamentally proficient in controlling the spread of HIV.10
77

Currently, COVID-19 vaccination coverage among adults varies among countries
with different levels of democracy. According to a 33-country study, data showed that
populations in China (91.3%), Indonesia (93.3%), Malaysia (94.3%), and Ecuador
(97.0%) would like to accept COVID-19 vaccines. However, the COVID-19 vaccine
acceptance rates in Kuwait (23.6%), Jordan (28.4%), Italy (53.7%), Russia (54.9%),
Poland (56.3%), US (56.9%), and France (58.9%) are found to be the lowest.82
Differences in vaccine acceptance rates may be attributed to health insurance, incentives,
social-economic factors, and level of democracy.83,84 In the context of re-emerging and
more transmissible variants of COVID-19, obstacles to reach herd immunity will be a
public health challenge for democratic countries.
Behavioral, social, and cultural diversities may intervene in disease transmission.
Housing units, education, employment, socioeconomic status, and health literacy are
different in democratic and authoritarian countries. These factors may lead to a higher
prevalence of COVID-19 in authoritarian countries.85 Citizens’ responses to government
measures have been observed in the different cultures between Asian, European, and
North American countries.86 As the pandemic continues to spread with less availability of
healthcare services within more underserved populations, for example, Africa, it should
become necessary to strategically manage healthcare systems and public health
dissemination.87
Our narrative review has several limitations. Since the rapidly changing situation,
we limited our online database search to retrieve articles published in the English
language from January 1, 2020, to August 16, 2021. We mainly focused on the
association between democracy and outcomes of COVID-19 and did not identify papers
regarding the role of democracy in other coronavirus outbreaks such as SARS. However,
the synthesized results emphasize the need for evidence concerning democracy and the
risk of these viral infectious diseases. To the best of our knowledge, this is the first
review on this topic. We believe our review strategies approach to be reliable for an
evolving pandemic.
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Conclusion
This systematic review revealed that democracy might be a risk factor for the
health outcomes of COVID-19. Future work is still needed. The ideal way to compare the
outcomes of COVID-19 across countries would match the countries in terms of the
covariates other than democracy level. Data in the existing literature have limitations,
such as the unavailability of data from developing countries. Extensive surveillance
should refine these data to strengthen public health policy and inform international aid
programs. Our systematic review provided policymakers and healthcare professionals
with relevant evidence to make effective decisions about public health policy to respond
to the pandemic.
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CHAPTER 3. DEMOCRACY AND CASE FATALITY RATE OF COVID-19 AT
EARLY STAGE OF PANDEMIC: A MULTICOUNTRY STUDY1

Introduction
COVID-19 poses a major global threat to humankind, inflicting devastating
consequences on the public health, politics, and economy of many countries.88 The World
Health Organization (WHO) announced that the novel coronavirus disease 2019
(COVID-19) outbreak was a public health emergency of international concern on January
30, 2020.19 On March 11, 2020, the COVID-19 outbreak officially became a pandemic,19
subsequently causing 191,686,787 confirmed cases and 4,112,533 deaths worldwide as of
July 20, 2021.21 The number of infections (as of July 20, 2021) are 23,677 times more
than the infections that occurred during the previous outbreak of severe acute respiratory
syndrome (SARS) from 2002 to 2003.11 In addition, according to the COVID-19
Dashboard managed by the Center for Systems Science and Engineering (CSSE) at Johns
Hopkins University, the number of confirmed cases and deaths related to COVID-19
varies dramatically across countries, which reflects findings that cannot be explained by
superficial analyses because the pandemic started earlier in some states and regions than
in others. In general, countries that score higher on the Democracy Index have healthier
populations,6,89 longer life expectancy,5,90 lower maternal and infant mortality,91 and
higher expenditures for healthcare services.92 The rationale that democracy could
improve health status is easy to understand. Firstly, when enforced through regular, free,
and fair elections, democratic countries have a greater incentive than autocratic countries
to provide welfare, health-related resources, and services to most of the citizens.6 In
addition, democratic countries are more communicative with a broader set of interest
groups, enjoy more freedom of media and press, and might be more active in utilizing the
feedback from interest groups to enhance national public health programs. On the
contrary, autocratic countries reduce political competition and access to information,
which might deter constituent feedback and responsive governance.5-8 However, it has
not been clear whether assessments of democracy in life expectancy and maternal and
infant health are generalizable to infectious diseases, particularly a pandemic, at the early
stage, which needs massive healthcare delivery, medical resources, healthcare
professionals, and the ability to enforce public health measures such as quarantine, maskwearing, pool testing, and other potential measures of preventing disease transmission.93
Many studies have explored population health, quarantine, medical, and economic
measures related to COVID-19, but few publications report on whether democracy is
related to COVID-19 mortality worldwide, especially for the disease outbreak at an early
stage.23-25 Karabulut and colleagues found that democracy is positively related to
infections.94 In 27 European countries, the Democracy Index and the political system (full

1

Modified from final submission by permission from Springer Nature. Environmental Science and
Pollution Research. Democracy and case fatality rate of COVID-19 at early stage of pandemic: a
multicountry study. Yao L, Li M, Wan JY, Howard SC, Bailey JE, Graff JC. 2021 Sep 7:1-11.99

21

democracy vs. authoritarian) were statistically correlated with mortality, where higher
scores on the Democracy Index were associated with higher mortality rates (p=0.003).95
Two theories suggest relevant domains to explore the relationship between
political systems and health. Political epidemiology theory developed by Arthur
Brownlea suggests that the role of politics in solving health issues rivals that of medical
interventions and epidemiological measures.29 Social epidemiology proposes that the
distribution of strengths and weaknesses in society echoes the distribution of disease and
health. The theory aims to identify societal features that influence the natural history of
diseases and their mechanisms.30
This study explores the association between democracy and the case fatality rate
of COVID-19 at the early stage of a pandemic based on global databases that allow
controlling for the effect of other risk factors. These risk factors include the percentage of
the population ages 65 and above, hospital beds per capita, health expenditure as a
percentage of GDP, the proportion of non-communicable diseases (NCD) caused deaths
of total deaths, healthcare workforce per capita, and population density. Notably, this
study evaluates a new predictor seldom used in health outcomes research. The
Democracy Index may correlate with the ability of governments to enforce mandated
public health measures during a pandemic.42 Further, the Democracy Index approximates
the extent to which a government can mandate the behavior of its citizens and how the
citizens react to the government.96 Mitigation of infectious disease transmission
profoundly depends on citizens’ attitude, behavior, response, and mobility.96-98 The study
team hypothesized that the Democracy Index score is negatively associated with the case
fatality rate of the COVID-19.99 The Approved Consent Form from Institutional Review
Board appears in Appendix C.

Methods

Data collection
COVID-19-confirmed cases, deaths, and tests performed
The study team collected data of cumulative confirmed COVID-19 cases and
deaths from the WHO open data repository accessed on October 25, 2020, a date chosen
to reflect the early period of the pandemic, when therapeutics were limited and no
vaccines had been approved.100 In addition, the team collected the total number of tests
and tests per 1,000,000 population from the COVID-19 Data Repository managed by the
Center for Systems Science and Engineering (CSSE) at Johns Hopkins University on
October 25, 2020.101 The case fatality rate (CFR) is defined as the number of individuals
who died of COVID-19 divided by the number of confirmed cases over a certain period
of time.102
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Democracy index
The dataset of the Economist Intelligence Unit’s Democracy Index 2019 provided
a snapshot of democracy worldwide and nearly covered the global population.42 The
Democracy Index uses Economist Intelligence Unit (EIU) data to evaluate the quality of
democracy as a composite score ranging from zero to ten. The Democracy Index
comprises 60 different aspects of society and includes all aspects of political and civic
life such as universal suffrage for adults, voter participation, perception of human rights
protection, and freedom to establish organizations and parties. The Democracy Index
2019 has five subscales that address the following: political culture, the functioning of
government, civil liberties, political participation, and electoral process and pluralism.
Data is obtained by experts’ assessment and scores are based on a range of indicators
within these five categories and the composite score is calculated as the mean of the five
categories. The Democracy Index is scored from zero to ten and grouped into four
clusters labeled full democracy (scored 8.0-10.0), flawed democracy (scored 6.0-7.9),
hybrid regime (scored 4.0-5.9), and authoritarian regime (scored 0.0-3.9). In addition, the
study team stratified countries as low-income, lower-middle-income, higher-middleincome, and high-income based on world bank definitions in 2020.103 Democracy Index
data were collected from the Economist Intelligence Unit database 2019.104
Covariates
Older age and presence of comorbidities are major risk factors for COVID-19
severity and mortality.105,106 The percentage of deaths caused by non-communicable
disease of the total deaths is an indicator for population who is more likely to be infected
by COVID-19.107 Healthcare workforce may also impact COVID-19 outcomes and was
modeled as the number of medical doctors, nurses, and midwives per 10,000
population.108 Population density (population per square kilometer),109 hospital beds per
1,000 population,110 health expenditure as a percentage of gross domestic product (GDP)
in US dollars,111 and the percentage of population ages 65 and above112 were taken into
account as covariates and collected from the World Bank and WHO databases.113,114

Data selection and preparation
The study team excluded countries that reported less than 2,000 confirmed cases
of COVID-19 and any country that had missing data in terms of any variable. The sample
size for main analyses was 148 countries while data from the 47 high-income countries
were analyzed separately.

Statistical analysis
Descriptive statistics, mean, median, standard deviation, and interquartile range
(IQR) were provided for all predictors. The study team implemented multiple linear
regression and negative binomial regression analyses. Both are widely applied to examine
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the association between potential explanatory factors and the cases, deaths, and case
fatality rate of COVID-19.111 The outcome variable was chosen as the case fatality rate,
which was calculated as the rate of cumulative deaths divided by cumulative confirmed
cases of COVID-19.115 Due to the highly skewed data across countries, log
transformation was performed prior to multiple linear regression analysis. The main
predictor variable was the Democracy Index score, and the outcome variable was the case
fatality rate. A series of variables were included as potential confounders and controlled
for in the regression model, including the percentage of the population ages 65 and
above, hospital beds per 10,000 population, population density, healthcare workforce per
capita, health expenditure as a percentage of GDP, and the percentage of deaths caused
by non-communicable disease of total deaths. Multiple linear regression was conducted
on two levels. The first set of analyses including the whole dataset of 148 countries and a
second set of analyses of the 47 high-income countries was stratified by the four country
income levels specified by the World Bank.113,114 The team employed statistical software
SAS (version 9.4) and the level of significance was set at α = 0.05.

Results

Variables summary
The initial analysis showed that the means of cumulative confirmed cases,
cumulative deaths, the case fatality rate, population density, the percentage of population
ages 65 and above, health expenditure as a percentage of GDP, the percentage of deaths
caused by non-communicable diseases of total deaths, healthcare workforce per 10,000
population, hospital beds per 1,000 population, and Democracy Index were 135,996.00,
4,325.00, 2.31%, 146.75, 9.35%, 6.54%, 68.88%, 63.02, 2.89, and 5.53, respectively
(Table 3-1).

Whole group analysis
Multiple linear regression
For the first level, Model 1 included the whole dataset of 148 countries. The R2
for Model 1 was 0.1479.The model is formulated as:
Y=0.00282+0.0039X1+0.0006X2+0.0039X3+0.0008X4-0.001X5-0.0028X60.0004X7
Y is dependent variable, log transformation of case fatality rate. X1 is population ages 65
and above (% of total population). X2 is the population density. X3 is the health
expenditure of GDP. X4 is non-communicable diseases caused deaths (% of total deaths).
X5 is healthcare workforce per capita. X6 is hospital beds per capita. X7 is the
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Table 3-1.

Descriptive statistics of variables (N=148)

Variables
Population ages 65 and abovea
Population densityb
Health expenditure of GDPc
NCD-caused deathsd
Healthcare workforcee
Hospital bedsf
Democracy Indexg
Cumulative casesh
Cumulative deathsi
Tests per 1,000,000 people
Case fatality ratej

Standard Interquartile
Mean
Median
deviation
range
9.35
6.81
6.76
11.86
146.75
80.28
248.65
111.00
6.54
6.43
2.41
3.59
68.88
76.60
22.78
44.25
63.02
44.39
56.34
82.01
2.89
2.10
2.44
3.15
5.53
5.78
2.24
3.84
135,996.00 34,470.00 252,530.00 115,870.00
4,325.00
491.50
10,806.00
2150.00
148,137.90 71,763.50 226,368.00 180,103.00
2.31
1.94
1.72
1.85

Notes: aPercentage of the population ages 65 and above.
b
Population per km2 of the country’s surface area.
c
Health expenditure as a percentage of the gross domestic product.
d
Percentage of deaths caused by non-communicable diseases of total deaths.
e
Total number of medical doctors, nurses, and midwives per 10,000 population.
f
Number of hospital beds per 1,000 population.
g
Democracy Index score (0 -10).
h,i
The starting points for cumulative cases and deaths were the confirmed days on
which the 50th case and 50th death occurred in each country.
j
Ratio of cumulative deaths from COVID-19 to cumulative cases of COVID-19
(expressed as a percentage).
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Index. β0 is 0.00282 which is the y-intercept when all other parameters are set to zero.
Hospital beds per 1,000 population were negatively correlated with the case
fatality rate of COVID-19 (β = -0.00282; p < 0.05). For this model, one could conclude
that increasing one hospital bed per 1,000 population would yield a 0.00282 decrease in
the case fatality rate of COVID-19 population. Conversely, the percentage of the
population ages 65 and above was positively associated with the case fatality rate (β
=0.00391; p < 0.05). Also, the health expenditure of the GDP was positively related to
the case fatality rate of COVID-19 (β =0.00397; p<0.05) (Table 3-2).
Negative binomial regression
Negative binomial regression was used to estimate the association between
predictors and counts of cases and deaths of COVID-19. The regression equations for
these models are shown as:
Log (Yc)=7.6639-0.0668X1-0.0003X2+-0.04420X3+0.0550X4-0.0034
X5+0.0698X6+0.1915X7
Log (Yd)=3.2351-0.0110X1-0.0010X2+0.0199X3+0.0648X4-0.0079X50.0649X6+0.1855X7
Yc is the counts of confirmed cases of COVID-19. Yd is the counts of deaths due to
COVID-19. X1 is population ages 65 and above (% of total population). X2 is the
population density. X3 is the health expenditure of GDP. X4 is non-communicable diseases
(NCD)-caused deaths (% of total deaths). X5 is healthcare workforce per capita. X6 is
hospital beds per capita. X7 is the Democracy Index.
Using these two regression models, we estimate that the percentage of deaths
caused by non-communicable diseases has a coefficient of 0.0648 with log count of
deaths due to COVID-19, which is statistically significant. One unit increase of deaths
caused by non-communicable diseases will change the log of counts of the COVID-19
related deaths by +0.0648 unit. In other words, one unit increase of deaths caused by noncommunicable diseases will raise the number of deaths due to COVID-19 by
exp(0.0648)-1 or 6.7%. What’s more, the regression for cases suggests that the
percentage of NCD-caused deaths of total deaths has a significant coefficient of 0.0550.
We expect that one unit increase of deaths caused by NCD of total deaths will change the
log of counts of the COVID-19 cases by +0.0550 unit. In other words, one unit increase
of deaths caused by NCD will raise the number of confirmed cases of COVID-19 by
exp(0.0550)-1 or 5.7%. Also, the Democracy Index has a significant coefficient of 0.1915
which shows that one unit increase in Democracy Index will change the log of counts
of the cases by +0.1915 unit. In other words, one unit increase in Democracy Index will
raise the number of confirmed cases of COVID-19 by exp(0.1915)-1 or 21%. In negative
binomial regression analyses of cases and deaths in 148 countries, health expenditure as a
share of GDP and Democracy Index are risk factors of COVID-19 related cases.
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Table 3-2.
Multiple linear regression results of the association between
predictors and case fatality rate of COVID-19 (N=148)

Variables
Population ages 65 and abovea
Population densityb
Health expenditure of GDPc
NCD-caused deathsd
Healthcare workforcee
Hospital bedsf
Democracy Indexg

Model
Parameter estimate (β)
0.0039
0.0006
0.0039
0.0008
-0.0010
-0.0028
-0.0004

(R2=0.1479)
p-Value
0.0193
0.1168
0.0237
0.7720
0.2958
0.0116
0.1747

Notes: aPercentage of the population ages 65 and above.
b
Population per km2 of the country’s surface area.
c
Health expenditure as a percentage of the gross domestic product.
d
Percentage of deaths caused by non-communicable diseases of total deaths.
e
Total number of medical doctors, nurses, and midwives per 10,000 population.
f
Number of hospital beds per 1,000 population.
g
Democracy Index score (0 -10).
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Meanwhile, health expenditure as a share of GDP is also a risk factor of deaths related to
COVID-19 (Tables 3-3 and 3-4).

Influence of democracy on the case fatality rate
Among the 148 countries in this research, 15% were labeled as full democracy,
31% as flawed democracy, 24% as hybrid regime, and 30% as authoritarian regime
countries. Categorized by income levels, 32% of countries were classified as high-income
followed by 28% higher-middle-income, 24% lower-middle-income, and 16% lowincome. Box plots demonstrated that cumulative confirmed cases, cumulative deaths,
tests per 1,000,000 population, and case fatality rates differed across the four regime
types. The variations between countries were significant due to the skewed data and
characteristics of countries. The highest confirmed cases appeared in countries within the
full democracy regime type, while countries having the least cases were attributed to
authoritarian countries. The case fatality rates in full democracy countries were higher
than that in most authoritarian and flawed democracy countries. Both lowest confirmed
cases and case fatality rate were observed among authoritarian countries (Figure 3-1).
Figure 3-2 presents the distribution of current health expenditure of GDP
compared side-by-side with four categories of regime type. Full democracy countries
invested least in the health sector than the others. Similarly, the percentage of the
population ages 65 and above was also the highest in full democracy countries (Figure
3-2).
As for the healthcare system, the healthcare workforce in full democracy
countries were the highest for distribution of health human resources followed by flawed
democracy, authoritarian regime, and hybrid regime. In addition, there were more
hospital beds per 1,000 population in democratic countries than in authoritarian countries
(Figure 3-3).

Subgroup analysis
Multiple linear regression
The model for the subgroup, 47 high-income countries, is calculated as:
Y=0.0382+0.0085X1+0.0002X2+0.0068X3-0.0024X4+0.0023X5-0.0075X60.0019X7
Y is the dependent variable, log transformation of case fatality rate. X1 is population ages
65 and above (% of total population). X2 is the population density. X3 is the health
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Table 3-3.
Negative binomial regression estimated association between
predictors and cases (N=148)
Variables
Odds ratio 95% Confidence interval
Population ages 65 and abovea
0.9353
(0.8535, 1.0251)
b
Population density
0.9997
(0.9986, 1.0007)
Health expenditure of GDPc
1.0565
(1.0360, 1.0773)
d
NCD-caused deaths
0.9568
(0.8388, 1.0913)
Healthcare workforcee
0.9966
(0.9883, 1.0051)
f
Hospital beds
1.0723
(0.9112, 1.2618)
Democracy Indexg
1.2110
(1.0256, 1.4299)
Notes: aPercentage of the population ages 65 and above.
b
Population per km2 of the country’s surface area.
c
Health expenditure as a percentage of the gross domestic product.
d
Percentage of deaths caused by non-communicable diseases of total deaths.
e
Total number of medical doctors, nurses, and midwives per 10,000 population.
f
Number of hospital beds per 1,000 population.
g
Democracy Index score (0 -10).

Table 3-4.
Negative binomial regression estimated association between
predictors and deaths (N=148)
Variables
Odds ratio 95% Confidence interval
a
Population ages 65 and above
0.9891
(0.8850, 1.1054)
b
Population density
0.9990
(0.9978, 1.0002)
Health expenditure of GDPc
1.0669
(1.0441, 1.0902)
NCD-caused deathsd
1.0201
(0.8762, 1.1877)
e
Healthcare workforce
0.9921
(0.9826, 1.0018)
Hospital bedsf
0.9372
(0.7747, 1.1338)
g
Democracy Index
1.2038
(0.9983, 1.4514)
Notes: aPercentage of the population ages 65 and above.
b
Population per km2 of the country’s surface area.
c
Health expenditure as a percentage of the gross domestic product.
d
Percentage of deaths caused by non-communicable diseases of total deaths.
e
Total number of medical doctors, nurses, and midwives per 10,000 population.
f
Number of hospital beds per 1,000 population.
g
Democracy Index score (0 -10).
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Figure 3-1. The cumulative confirmed cases and deaths of COVID-19, tests per
1,000,000 population, and case fatality rate distribution by regime type
Notes: The x-axis represents the four types of regimes in the order of “Authoritarian
Regime”, “Hybrid Regime”, “Flawed Democracy” and “Full Democracy.” Y-axis units
are displayed in parentheses. (A) y-axis indicates the cumulative confirmed cases per
1,000,000 population. (B) y-axis indicates the cumulative deaths per 10,000 population.
(C ) y-axis indicates the tests per 1,000,000 population. (D) y-axis indicates the case
fatality rate (%).
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Figure 3-2. Health expenditure of GDP and percentage of population ages 65 and
above distribution by regime type
Notes: (A) x-axis represents the four types of regimes in the order of “Authoritarian
Regime”, “Hybrid Regime”, “Flawed Democracy” and “Full Democracy”, y-axis
indicates the health expenditure as a percentage of GDP (in US dollars). (B) y-axis
indicates the percentage of population ages 65 and above.
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Figure 3-3. Healthcare workforce per 10,000 population and hospital beds per
1,000 population distribution by regime type
Notes: (A) x-axis represents the four types of regimes in the order of “Authoritarian
Regime”, “Hybrid Regime”, “Flawed Democracy” and “Full Democracy”, y-axis
indicates healthcare workforce per 10,000 population. (B) y-axis indicates hospital beds
per 1,000 population.
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expenditure of GDP. X4 is NCD-caused deaths (% of total deaths). X5 is healthcare
workforce per capita. X6 is hospital beds per capita. X7 is the Democracy Index. β0 is
0.0382 which is the y-intercept when all other parameters are set to 0.
Based on the calculation using the equation above, we obtained the results of
association estimation (Table 3-5). Within 47 high-income countries, hospital beds per
1,000 population were negatively correlated with the case fatality rate of COVID-19 (β
=-0.00754; p < 0.05). For the second model, increasing one hospital bed per 1,000
population yields a 0.00754 decrease in the case fatality rate of COVID-19 population.
On the contrary, the percentage of population ages 65 and above was also positively
associated with the case fatality rate (β =0.00858; p < 0.05). Finally, the Democracy
Index was negatively correlated with the case fatality rate of COVID-19 (β =-0.00192; p
< 0.05). However, the effect of health expenditure of GDP did not reach a significant
level among high-income countries as shown in Model 2.
Negative binomial regression
Negative binomial regression was used to estimate the association between
predictors and cases as well as deaths of COVID-19. The negative binomial regression
models are formulated as following:
Log (Yc)=9.8196+0.0165X1-0.0009X2+0.0363X3+0.5538X4-0.0058X50.1072X6-0.6046X7
Log (Yd)=1.7414-0.0626X1-0.0015X2+0.7034X3+0.0711X4-0.0055X50.1705X6-0.6480X7
Yc and Yd represents the counts of COVID-19-related cases and deaths respectively. X1
is population ages 65 and above (% of total population). X2 is the population density. X3
is the health expenditure of GDP. X4 is NCD-caused deaths (% of total deaths). X5 is
healthcare workforce per capita. X6 is hospital beds per capita. X7 is the Democracy
Index.
In subgroup analysis, negative binomial regressions for deaths counts show that
health expenditure as a percentage of GDP has a significant coefficient of 0.7034 with
deaths of COVID-19. We estimate that one unit increase in health expenditure as a
percentage of GDP will change the log of counts of the COVID-19-related deaths by
+0.7034 unit. In other words, one unit increase in health expenditure as a percentage of
GDP will raise the counts of the COVID-19-related deaths by exp(0.7034)-1 or 102%. In
contrast, Democracy Index has a coefficient of -0.6480 which indicates that one unit
increase in Democracy Index will change the log of counts of COVID-19 deaths by0.6480 unit. In other words, one unit increase in Democracy Index will lower the counts
of COVID-19 deaths by 1-exp(-0.6480) or 48%. In addition, regression analysis
for cases suggests that the health expenditure of GDP is a significant predictor with a
coefficient of 0.0363. This result means that one unit increase in health expenditure of
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Table 3-5.
Multiple linear regression results of the association between
predictors and case fatality rate of COVID-19 in high-income countries (N=47)

Variables
Population ages 65 and abovea
Population densityb
Health expenditure of GDPc
NCD-caused deathsd
Healthcare workforcee
Hospital bedsf
Democracy Indexg

Model
Parameter estimate (β)
0.0085
0.0002
0.0068
-0.0024
0.0023
-0.0075
-0.0019

(R2=0.3857)
p-Value
0.0249
0.6866
0.1313
0.8982
0.2680
0.0056
0.0490

Notes: aPercentage of the population ages 65 and above.
b
Population per km2 of the country’s surface area.
c
Health expenditure as a percentage of the gross domestic product.
d
Percentage of deaths caused by non-communicable diseases of total deaths.
e
Total number of medical doctors, nurses, and midwives per 10,000 population.
f
Number of hospital beds per 1,000 population.
g
Democracy Index score (0 -10).
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GDP will change the log counts of the cases by +0.0363 unit. In other words, one unit
increase in health expenditure of GDP will raise the counts of the cases by exp(0.0363)-1
or 3.7%. Furthermore, the Democracy Index has a significant negative coefficient of 0.6046 which indicates that one unit increase in Democracy Index will change the log of
counts of the cases by -0.6046 unit. In other words, one unit increase in Democracy Index
will lower the counts of the cases by 1-exp(-0.6046) or 45%. The negative binomial
regression analyses showed that, in 47 high income countries, health expenditure as a
share of GDP is a risk factor of cases while Democracy Index is the only protective factor
for COVID-19 related cases. The analysis concerning COVID-19 related deaths
suggested that health expenditure as a share of GDP is a risk factor of deaths and
Democracy Index remained a protective factor in high income countries (Table 3-6 and
3-7).

Discussion
When adjusting predictors included in this analysis, the Democracy Index score
was not statistically related to the case fatality of COVID-19 among the 148 countries.
However, after stratifying by income levels, the Democracy Index score was negatively
associated with the case fatality rate of COVID-19 patients within the 47 high-income
countries. This finding highlighted an association between level of democracy according
to the Democracy Index 2019 and the capacity of high-income countries to legitimate
sufficient public health response to an urgent health crisis like COVID-19 in high-income
countries.
Based on the multiple linear regression analysis, population density was not
associated with case fatality rates in 148 countries. Scholars have argued that high
population density contributed to the transmission of COVID-19.116 However, urgent
lockdown and social distance policies, especially in authoritarian countries, and mandated
measures to their citizens might reduce the possibility of human-to-human transmission
(HHT).117 Although the Democracy Index variable was not a significant predictor in the
first multiple linear regression model, those authoritarian countries are more likely to
legitimate emergent and effective public health measures announced by the central
governments. Like driving under the influence (DUI) is illegal because of threatening
other people’s lives and safety temporarily mandated measures responding to pandemics
should be separated from suppression of citizens’ democracy and freedom. Otherwise,
the time for countries weighing the trade-off between mandates and suggestive measures
would possibly lose the critical point of mitigation.
This empirical study fills the gap of current knowledge that concentrates on the
extent to which the health care system and health policy can mitigate the spreading of
COVID-19 across countries and regions.118,119 Although some scholars have debated the
association between deaths and healthcare resource distribution, such as personal
protective equipment (PPE) allocation in Italy,120 little is known about the influence of
healthcare human resources. The healthcare workforce did not relate to the case fatality
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Table 3-6.
Negative binomial regression estimated association between
predictors and cases in high-income countries (N=47)
Variables
Odds ratio 95% Confidence interval
Population ages 65 and abovea
1.0166
(0.8523, 1.2126)
b
Population density
0.9991
(0.9976, 1.0006)
Health expenditure of GDPc
1.7398
(1.2872, 2.3517)
d
NCD-caused deaths
1.0370
(0.9132, 1.1776)
Healthcare workforcee
0.9942
(0.9848, 1.0037)
f
Hospital beds
0.8983
(0.7288, 1.1072)
Democracy Indexg
0.5463
(0.3660, 0.8155)
Notes: aPercentage of the population ages 65 and above.
b
Population per km2 of the country’s surface area.
c
Health expenditure as a percentage of the gross domestic product.
d
Percentage of deaths caused by non-communicable diseases of total deaths.
e
Total number of medical doctors, nurses, and midwives per 10,000 population.
f
Number of hospital beds per 1,000 population.
g
Democracy Index score (0 -10).

Table 3-7.
Negative binomial regression estimated association between
predictors and deaths in high-income countries (N=47)
Variables
Odds ratio 95% Confidence interval
a
Population ages 65 and above
1.0646
(0.8538, 1.3275)
b
Population density
0.9985
(0.9969, 1.0002)
Health expenditure of GDPc
2.0206
(1.3797, 2.9593)
NCD-caused deathsd
1.0737
(0.9127, 1.2631)
e
Healthcare workforce
0.9945
(0.9834, 1.0057)
Hospital bedsf
0.8433
(0.6691, 1.0628)
g
Democracy Index
0.5231
(0.3441, 0.7952)
Notes: aPercentage of the population ages 65 and above.
b
Population per km2 of the country’s surface area.
c
Health expenditure as a percentage of the gross domestic product.
d
Percentage of deaths caused by non-communicable diseases of total deaths.
e
Total number of medical doctors, nurses, and midwives per 10,000 population.
f
Number of hospital beds per 1,000 population.
g
Democracy Index score (0 -10).
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rate of COVID-19. One explanation may be due to the overwhelming number of patients
and the saturation of healthcare systems by the influx of patients. As the pandemic has
continued to develop through 2021, health professionals have faced another
unprecedented challenge: an overwhelming number of patients and more reproductive
variants. Determining the healthcare system’s constraints and the correlated factors to be
examined in future research is critical. For instance, one case study of the United States
evaluated and concluded that healthcare resource distribution equity could enhance the
effectiveness of protecting citizens against the infection and deaths from COVID19.119,121 However, democratic countries neglected to implement long-term, sustainable
strategies to reinforce the healthcare system to manage the abrupt shift in demand in
terms of the healthcare workforce and resources caused by the COVID-19 crisis.
The result was as expected: a higher percentage of population ages 65 and above
was positively correlated with higher case fatality rates among 148 countries. Therefore,
this confirms that coronavirus is more fatal for the aged population regardless of race.122
Unexpectedly, the percentage of deaths caused by non-communicable disease of total
deaths did not reach statistical significance. The previous research suggested that the
clinical outcomes of the patients with comorbidities are worse than those without
underlying health conditions.123 However, the most recent studies claim that, at the peak
of the pandemic, comorbidities did not have associations with the mortality of COVID19. While diabetes, cardiovascular diseases, and hypertension are the most frequent
comorbidities diagnosed among COVID-19 patients who are more likely to develop
severe disease, the current study does not provide clear evidence that the prevalence of
comorbidities at the country level increases overall risk of deaths from COVID-19.124,125
Although underlying health conditions often exacerbate a person’s illness from the novel
coronavirus, the interpretation that comorbidities relate to death rather than the viral
infection is incorrect.
One surprising result was the positive relationship between the health expenditure
as a percentage of GDP and the case fatality rates of COVID-19. The patients with
COVID-19 related did not benefit from living in countries with higher health expenditure
of GDP. This result is different from those in previous reports.126 The health expenditure
of GDP contains several divisions of investment while countries differ dramatically on a
budget of preventive medicine, clinical medicine, and research and development of
cutting-edge equipment.127 Healthcare capacity or functionality from an infectious
disease perspective may be sensitive to decisions about allocation well in advance of the
pandemic. For high-income countries, chronic diseases are classified as a top priority
instead of infectious diseases.128 Countries spending more on health expenditure are those
with a higher proportion of senior citizens. On the other hand, countries with higher
healthcare costs are more likely to test their citizens and report the confirmed cases and
deaths.
Findings from the analysis of high income countries support our hypothesis and
indicate a negative association between democracy and health outcomes of COVID-19,
which coincides with previous studies on the relationship between democracy, maternal
and infant mortality rates, and HIV/AIDS prevalence.5,7,10 Increasing empirical analyses
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show that pandemic-related factors cannot solely explain the considerable variation of
outcomes across countries. Engler and colleagues suggested that the established
democratic principles before the pandemic makes democratic governments reluctant to
implement mandatory health policies.129 Thus, we believe that the Democracy Index
explains the variation of countries’ responses to COVID-19; that is, the higher the
democracy level, the less the restriction of citizens’ freedoms and the national public
health policy. As a result, democratic governments more likely respond with self-control
public health measures without stringent interventions.129,130 These may lead to increased
transmission, infections, and deaths.
The results suggest that democracy might be a risk factor in high-income
countries. The hospital beds, healthcare workforce, health expenditure of GDP may be
protective factors. Because of the variations across countries, we suspect that some
potential factors and mechanisms are likely mediating the predictors and health
outcomes. Future research in this field is needed to evaluate the effect of democracy in
two-way directions. The pandemic may also affect the level of democracy across
countries.
The main findings of this study are subject to several limitations. First, due to the
self-reported confirmed cases and deaths collected from different countries, the open-use
datasets provided by international institutions and organizations may have variations of
measurements across countries. Second, the confirmed cases of COVID-19 likely are
underestimated because of the capacity of testing for each country and scarcity of
medical resources, particularly within some low-income countries; for example, the PCR
testing kits will limit the numerator of the morbidity rate.128 Conversely, the mortality of
COVID-19 is likely to be overestimated because of excess deaths. The Democracy Index
data may include bias with respect to the instruments and evaluations which are limited to
epidemiological research. Third, data collected for the original goal or purpose might be
difficult to utilize to respond to different research questions. Finally, because the current
research employed a non-experimental cross-sectional study design, any demonstrated
associations cannot be assumed to be causal. There are many alternative explanations for
the demonstrated associations and also substantial heterogeneity among countries with
both democratic and authoritarian governments. Thus, it is entirely likely that factors
other than democracy may explain the observed variability in COVID-19 mortality. The
stratified data within low-income, lower-middle-income, and higher-middle-income
countries did not show any patterns or relations, possibly due to the relevance of
predictors and variations among different levels of incomes. However, future research
could leverage a retrospective research design to elucidate unanswered questions in this
study.

Conclusion
This multicountry study suggests that health expenditure of GDP, hospital beds
per capita, and population ages 65 and above were associated with the case fatality rates
of COVID-19. However, none of these can be quickly modified in the setting of a
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pandemic, so prior preparation with excess capacity may be warranted. To our surprise, a
lower Democracy Index score (more authoritarian government) was strongly and
independently associated with decreased numbers of cases and decreased case fatality
rate from COVID-19, suggesting that the ability to enforce health mandates on the
population may be the most important element in response to a pandemic. Countries with
a high Democracy Index score should consider policies that allow the healthcare
equivalent of martial law so that any future pandemic can be controlled more effectively.
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CHAPTER 4. GRAPHICAL TRAJECTORY COMPARISON TO IDENTIFY
ERRORS IN DATA OF COVID-19: A CROSS-COUNTRY ANALYSIS2

Introduction
Despite advances in microbiology and molecular diagnostics, timely identification
of a new infectious disease such as COVID-19, its transmission pattern, hazard to
humans, and case fatality rate, remains challenging.93,131-133 Investigators and clinicians in
Wuhan quickly identified the novel coronavirus SARS-CoV-2 and disseminated their
findings to the global community but determining the exact date of onset in Wuhan and
the dates of initial arrival to other cities has been problematic.134 Moreover, before mass
testing programs were initiated, researchers could determine the exact counts of COVID19 cases in Wuhan during the first quarter of the pandemic.134 However, accurate
estimation of the date of virus onset in each locale and anticipation of future cases and
deaths are necessary to prevent, predict, and mitigate the impact of new potentially lethal
communicable diseases.
Since COVID-19 attacked the world, the term “turning point” appears frequently
in the news, reports, and publications. From the perspective of epidemiology, the “turning
point” means when an infectious disease reaches a point beyond any local ability to
control it from spreading more widely.134 In general, the cases and deaths from the
COVID-19 pandemic are expected to decrease after their turning points in a country or
region. Unfortunately, new waves of COVID-19 have been observed in many countries
and regions. To date, the meaning of the turning point for the development of the
pandemic has received scant attention in the research literature. In this study, the turning
point indicates the peak of cases or deaths in a single wave of COVID-19.
The turning points of cases and deaths caused by COVID-19 across regions and
countries provide a useful tool to reexamine the data in the early stage of the Wuhan
outbreak.133,135 By reviewing and comparing the turning point dates of the COVID-19
pandemic in sampled countries, the disease pattern and trajectory are evident. Despite the
multiple waves of disease, some regions and countries, such as China, Hong Kong, South
Korea, Switzerland, and Israel, effectively mitigated the epidemic of COVID-19 at the
early stages of transmission.131 From the retrospective investigations of cases, deaths, and
calendar days, we found similar patterns in these countries.
We analyzed patterns of turning points of several regions and countries for which
robust data on the incidence and timing of COVID-19 cases and deaths were available.
We then developed a predictive model to estimate the dates of onset and turning point
and applied the model to the early Wuhan pandemic to estimate the date of onset in this
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and other areas for which early data were less robust due to their timing early in the
pandemic.136

Methods

Data collection in the early stage of the pandemic
We collected data on COVID-19 cases in China and other countries from official
and publicly accessible websites.132,134 We collected the daily new cases and deaths from
the first day of the official reports within regions and countries. The cases and deaths
addressed in this study referred to new cases and new deaths. Because COVID-19 was
largely under control in China and a few other countries, early data were collected on or
before the end of June 2020. When a country did not report the data for new cases or
deaths in a single day, the cumulative cases and deaths reported before and after the
missing data day were used to estimate the cases and deaths for that specific day. The
pandemic period is the interval from the day of the first case to the day in which there
were less than 10 cases.

Peak day of cases and deaths
For the peak day of a country, we used the weighted number method.132 Thus, the
peak day of cases is defined as the day with the largest number of average cases of every
three, five, and seven days. Similarly, the peak day of deaths is also calculated by the
largest number of average deaths of every three, five, and seven days. There will be a
maximum of three days of peaks if the peak days from three, five, or seven days are
different from each other. For example, if the average deaths of every seven days are the
largest number among average numbers of every three, five, and seven days, then the
average number of deaths of every seven days will be the deaths peak day. The number
of days between the peak days of cases and deaths is defined as the time lag. The peak
period is defined as the first day with cases or deaths equal to or more than 40% of the
numbers in the cases or deaths peak day to the last day with numbers equal to or more
than 40% of the case or death numbers in the cases or deaths peak day, which is 13 days
based on previous research.132

Data analyses before and after the peak day
The number of days of the pandemic before and after the cases peak day and
deaths peak day was calculated and compared to rates of SARS-CoV-2 infection and
mortality. For cases, the days before and after the cases peak day were calculated
respectively and compared to the total days of the study period in different regions/countries. Similarly, the days before and after the deaths peak day were compared to the
total number of total days of the study period. The cases peak day and the deaths peak
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day were not counted in the number of days either before or after the peak days.132 The
term, disease peak, has also been used in the study of characteristics of COVID-19 by
other researchers.132,133,135 Here we use the term disease peak to define the days of the
highest number of cases and deaths as cases peak day and deaths peak day, respectively.

The time lag between peaks of cases and deaths
The time lag is defined as the number of days between the cases peak day and the
deaths peak day, as calculated based on the paired comparison between three, five, and
seven days of the peak day of cases and deaths. The time lags of different countries were
calculated. The features of the time lag among countries included the number of days, the
proportion of time lag over the total days of the pandemic period, and the proportion of
deaths during the time lag over the total deaths. Mathematical calculations in time lag
included the numbers in the cases peak day and deaths peak day. The features of the peak
period included the duration of time lag, the ratio of time lag to the pandemic period, and
the ratio of the cases and deaths to the total cases and total deaths. These features were
analyzed among the countries with different pandemic duration and infectious disease
outbreak scales.

Results

Basic information
Table 4-1 summarizes the numeric indicators of cases and deaths of COVID-19
in sampled regions and countries. There was considerable difference in time lag and
numbers of cases and deaths among different countries/regions. The time lag ranged from
0 to 23 days. The case number at peak day ranged from 244 (Huanggang) to 42,941
(Brazil) and the number of deaths at peak day varied from 6 (Huanggang) to 2,332
(United States). There was less difference among the days in the peak period of cases and
deaths, extending from 7 to 53 and from 22 to 53, respectively.

Case and death patterns in Hubei province
We compared the cases and deaths in Xiaogan, Huanggang, and Wuhan in
China’s Hubei province. As shown in Figure 4-1, we identified peak periods in cases and
deaths in each graph and highlighted the time lags in the overlap of cases and deaths.
In Xiaogan, the peak period of cases was between January 30 to February 9, 2020.
The turning point or peak day was February 5, 2020. The peak period of deaths was from
February 4 to February 25; the peak day or turning point of deaths was February 18. The
length of the time lag was 13 days (Figure 4-1A).
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Table 4-1.

Summary of indicators of cases and deaths of sampled regions and countries using data of an average of 7-day
Indicators
Time lag
Cases in peak day
Deaths in peak day
Cases in peak period
Deaths in peak period
Cases in time lag
Deaths in time lag
Cases after peak day
Total cases
Deaths after peak day
Total deaths
Cases peak period
Deaths peak period
Peak cases /total cases
Peak deaths /total deaths
Cases after peak/total cases
Deaths after peak /total deaths
Cases in time lag /total cases
Deaths in time lag /total deaths

Xiaogan
13
424
7
1,846
64
1,846
64
1,533
3,419
58
128
11
22
0.124
0.055
0.448
0.453
0.540
0.500

Huanggang
12
244
6
2,578
110
1,815
54
1,638
2,884
56
125
17
31
0.894
0.880
0.568
0.448
0.629
0.432

Wuhan
0
3,910
88
25,393
1,880
0
0
32,994
50,860
1,036
2,606
7
22
0.499
0.721
0.649
0.398
0.000
0.000

Switzerland
15
1,100
57
22,890
1,594
14,794
643
23,098
30,572
1,114
1,879
27
36
0.749
0.848
0.756
0.593
0.484
0.342

Japan
22
615
24
11,065
617
8,330
428
10,232
16,237
238
725
25
35
0.681
0.851
0.360
0.328
0.513
0.590

Austria
16
796
25
10,449
491
7,659
245
10,613
16,201
356
629
18
29
0.645
0.781
0.655
0.566
0.473
0.390

United States
7
32,901
2,332
1,461,040
86,251
241,640
17,263
1,039,256
1,516,575
55,330
90,324
53
47
0.963
0.955
0.685
0.613
0.159
0.191

Brazil
-23
42,941
1,165
903,395
48,766
723,396
24,831
0
1,280,063
23,562
56,109
32
53
0.706
0.869
0.000
0.420
0.565
0.443

Russia
16
11,028
140
330,374
3,252
154,751
1,806
152654
362,380
174
3,807
39
33
0.912
0.854
0.421
0.046
0.427
0.474

Data sources: The data of Wuhan, Huanggang, and Xiaogan were collected from the Health Commission of Hubei Province at
http://wjw.hubei.gov.cn/fbjd/dtyw/ (Accessed June 30, 2020).137 The data of Switzerland, Japan, Austria, the United States, Brazil,
and Russia are available in the repository from Worldometers at https://www.worldometers.info/coronavirus/ (Accessed June 30,
2020).138
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Figure 4-1. Patterns of cases and deaths from COVID-19 in three cities in China’s
Hubei province from January 19 to March 19, 2020
Notes: (A) New cases and deaths in Xiaogan; (B) New cases and deaths in Huanggang;
(C) New cases and deaths in Wuhan.
Data source: The data of Wuhan, Huanggang, and Xiaogan were collected from the
Health Commission of Hubei Province at http://wjw.hubei.gov.cn/fbjd/dtyw/ (Accessed
June 30, 2020).137
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In Huanggang, the cases peak period was from January 28 to February 13; the
peak day or turning point of cases was February 2. The deaths peak period was from
January 28 to February 27; the peak day or turning point of deaths was February 14. The
length of the time lag was 12 days (Figure 4-1B).
The length of time lag represents the average number of days from the onset of
symptoms to the deaths in the infected population. Thus, most deaths will not occur on
the same day when most cases occur. However, when we examined the data reported
from Wuhan, the result was not consistent with other cities. Figure 4-1C shows the cases
peak period (February 9 to February 15) and deaths peak period (February 4 to February
25), but the turning point of cases and deaths were the same (February 13). Therefore,
there was no time lag in Wuhan.

Case and death patterns in three countries with less disease severity
To further support the findings that the peak day of cases is before the peak day of
deaths, we examined the cases and deaths in Switzerland, Austria, and Japan (Figure
4-2). Similar to data from China, cases and deaths in these three countries followed the
patterns in the two cities in China. The first peak was the peak of cases, while the last
peak was the peak of deaths. The length of time lag was 15 days in Switzerland, 16 days
in Austria, and 22 days in Japan.

Case and death patterns in three countries with large pandemics
We chose to examine early data from the United States, Brazil, and Russia, where
people are still suffering from the pandemic. COVID-19 in these countries was
progressing, but their patterns were different as shown in Figure 4-3. In the United
States, the peak days of cases and deaths could be distinguished, and the time lag was 11
days. In Russia, the situation was approximately the same as the trajectory of Xiaogan
and Huanggang in China; the time lag was 16 days. However, in Brazil, the peak of
deaths came earlier than the peak of cases; the length of time lag was 23 days (Figure
4-3).

Patterns of death rate around the peak of disease onset
To examine in detail the pandemic onset and the deaths of COVID-19 in Wuhan
and to make comparisons across countries, we calculated the case fatality rate according
to the 7-day period in Wuhan and sampled countries around the case peak. The case
fatality rate of 13 days before and after the onset peak was calculated according to
reported information.139 As shown in Figure 4-4, although the patterns of case fatality
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Figure 4-2.

Patterns of cases and deaths from COVID-19 in three countries

Notes: (A) New cases and deaths in Switzerland; (B) New cases and deaths in Austria;
(C) New cases and deaths in Japan.
Data source: The data of Switzerland, Japan, and Austria are available in the repository
from Worldometers at https://www.worldometers.info/coronavirus/ (Accessed June 30,
2020).138
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Figure 4-3. Patterns of death in three different countries with persistently high
numbers of COVID-19 cases
Notes: (A) New cases and new deaths in the United States; (B) New cases and new
deaths in Brazil; (C) New cases and new deaths in Russia.
Data source: The data of the United States, Brazil, and Russia are available in the
repository from Worldometers at https://www.worldometers.info/coronavirus/ (Accessed
June 30, 2020).138
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Figure 4-4. The graphic trajectory comparing COVID-19 death rates between
Wuhan and five countries
Notes: X-axis represents date of observations. Y-axis indicates the death rate (%). Daily,
3 day average, 5 day average, 7 day average are the average death rates of every day, 3
days, 5 days, and 7 days. The average means the average death rates of daily, 3 days, 5
days, and 7 days in total.
Data sources: The data of Wuhan were collected from the Health Commission of Hubei
Province at http://wjw.hubei.gov.cn/fbjd/dtyw/ (Accessed June 30, 2020).137 The data of
Switzerland, Japan, Austria, the United States, and Russia are available in the repository
from Worldometers at https://www.worldometers.info/coronavirus/ (Accessed June 30,
2020).138
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rate in the period around the onset peak in six countries appeared as relatively smooth
slopes, the pattern in Wuhan had a drastic increase around 10 days after the disease onset
peak. This unique pattern also differed from other regions and countries.

Estimated peak day and cases in Wuhan
According to the data from these countries, several circumstances could explain
Wuhan’s divergent results compared to other regions and countries. First, the time lag
between peak days of cases and deaths was between 11 to 23 days with an average of
15.5 days. We speculate that the actual peak day of case fatality rate in Wuhan was
around January 30, earlier than the reported February 13. The day of early disease onset
may also be 30 days before its first reported case.140 Given that the ratio between reported
deaths and cases ranged from 1% to 2%, we speculate that the actual number of cases in
Wuhan on the peak day was between 6,000 to 12,000, while the reported average number
of cases over a 7-day was 4,800 (Table 4-1).

Potential data collection errors in Brazil
The surprising finding is that the peak of deaths occurred earlier than the peak of
cases in Brazil. The death peak day was June 2, 2020, while the case peak day occurred
on June 26, 2020 (Figure 4-3B). If we assume that the reported deaths are more accurate
than those of the cases and the disease pattern of the pandemic in Brazil is the same as
other countries, there should be a peak day of cases observed around May 20, 2020.
However, reporting bias in the counts of deaths, or the counts of both deaths and cases
and improvement in clinical treatment may have led to these findings.

Discussion
Different countries may show different patterns of cases peak days, deaths peak
days, and peak periods. The graphical trajectory analysis reveals significant
underestimates in the early reporting of COVID-19 in Wuhan. Such an underestimation
may be caused by incomplete data collection in the early stage of the disease, which
generally is the case in the early stage of a novel disease.131 The data collection of
COVID-19 outcomes in Wuhan are based on surveillance data with correction for
reporting bias. Aggregating data from regional and national sources, we conclude that the
official statistics in Wuhan are less than the actual transmission scale of the epidemic,
and this finding can be generalized to some countries where the heavy burden of disease
has lasted for several months. Implementing mandatory health policies that emphasize
social distancing, pooled testing, and wearing masks offers a promise to fight against the
pandemic until vaccinations and herd immunity become effective.93
The statistical confusion around the cases and deaths peak days in Brazil remains
a puzzle. In addition to a validation problem in data collection, there are multiple reasons
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for such a trajectory. First, an error in data collection and analysis, such as statistical
analysis or technical errors, could lead to such a result. Second, if the clinical treatment
was dramatically improved later, the deaths peak day could occur earlier. Third, if
environmental conditions, such as temperature, lead to an early high death rate, and later
the death rate decreases because of the high temperature, the deaths peak day may occur
earlier than the cases peak day.141 Furthermore, because the pandemic in Brazil is still not
under control, the overall pattern may change in the future.
The differences between surveillance statistics and our estimates may be due to
various measurement and health policy limitations. The capacity of testing sites was a
major obstacle for detecting cases in Wuhan at the early stage of the epidemic. Citizens
with mild symptoms did not have access to testing and healthcare service. Most COVID19 testing was performed on hospitalized patients, and a few qualified laboratories
serving a large population postponed reporting the results. Biases on the number of cases
are most likely caused by the large number of asymptomatic and mild cases that did not
report themselves or were not tested or diagnosed. Moreover, the overwhelmed
healthcare system of Wuhan in the early stages of the outbreak could not provide
sufficient services to the COVID-19 patients with mild symptoms. Last but not least, the
false positive and false negative results of COVID-19 testing may have contributed to
inaccurate data.142,143
The biases of underestimating the cases and deaths were not limited to Wuhan.
Due to the incubation period, asymptomatic carriers, sensitivity and specificity of tests,
and testing capacity, underestimating outcomes is common; however, their impact will
vary across countries. Even given sufficient testing capacity, both the asymptomatic
patients and false-negative results would underestimate the number of cases.144
Essentially, policymakers and healthcare professionals may encounter a substantial
underestimate of the actual number of cases and thus misunderstand the development of
the pandemic. We hope that this straightforward graphical trajectory approach can be
used for similar conditions to eliminate bias.
In addition, these biases involve time-dependent reporting of cases and deaths and
time lags in COVID-19 outcomes. In the situation of estimating COVID-19 time lag, we
identify the biases and their possible relevance. Further, we provide a partially corrected
estimation of these biased data from time lag and incomplete reporting of cases and
deaths. This study shows that contact tracing of infected individuals despite the presence
of symptoms will alleviate bias by controlling the correlation between diagnosis and
deaths.
Researchers have established models to predict the progression of COVID-19,52
such as estimation of cases and deaths based on algorithms,132 deep learning models for
predicting severe progression,145 and prospective validation studies of prognostic
biomarkers to predict adverse outcomes.146 Our study is an evidence-based comparison
and prediction, which is different from typical statistical models.
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In this article, we discuss the remaining situations that need to be considered.
First, all data were derived from website data reported by each region or country.
Variations in the measurement of cases and deaths in the early stage of the pandemic may
exist, which is one reason there is no time lag in Wuhan. Second, countries with
progressive COVID-19 require long-term attention as the existing data lead to a limited
understanding of the situation. Third, studies have demonstrated that the durations from
being infected with COVID-19 to death vary from 1 to 21 days,140,147 while the death
peak appears about 13 days after infection.140 The causes of the same peaks of cases and
deaths in Wuhan could be multifold, including the urgent shortage of medical facilities,
which led to the immediate or excessive deaths, the reporting biases of cases and deaths,
and the insufficient contact tracing of infected individuals. One of the errors in early
Wuhan data was its high mortality rate which had been calculated as high as 20% at the
early stage of the epidemic.132 If the death peak was earlier than that of the case peak, this
is evidence that the data were not valid.

Conclusion
Our simulated graphical trajectory method identifies statistical biases in
surveillance data. This approach incorporates all sources of available data and provides a
robust method to characterize the time course of an infectious disease. Regions and
countries beginning with high mortality rates from the COVID-19 epidemic will suffer a
long, painful period of the disease epidemic. Where the mortality rate is relatively high,
healthcare professionals should prepare for a longer period of fighting this pandemic.
Data quality is key to case fatality rate estimation which is needed by policymakers to
make correct and timely critical decisions.
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CHAPTER 5.

CONCLUSIONS

Summary of Findings
This section summarized the main findings of our research. The primary research
aim was to assess the relationship between democracy and case fatality rate of COVID19. The research aims to provide answers to this primary question by answering the
following sub-questions.
Chapter 2 aimed to explore and evaluate the relevant evidence in democracy and
health outcomes and better understand the associations between democracy and health
outcomes of COVID-19. First, we searched PubMed and other two databases with
keywords. The rapid systematic review showed that social-political factors, especially,
democracy, exert an effect on life expectancy, maternal and infant mortality. Besides, the
social-political factors also impact the transmission and health outcomes of infectious
diseases, such as HIV/AIDS and SARS. Eventually, we synthesized the current literature
about non-pharmaceutical interventions and found a set of predictors that may be
associated with the severe consequences of the COVID-19 pandemic. Eventually, we
focused on the predictors of health outcomes of COVID-19, meanwhile evaluated the
strengths and weaknesses of the existing literature. The essential finding was a lack of
multicountry studies that use comprehensive measurements of predictors to assess the
relationship between democracy and health outcomes of COVID-19.
Chapter 3 intended to examine the relationships between a specific political
predictor, that is, the Democracy Index, and the case fatality rate of COVID-19 across
countries. In addition, it also examines the other factors, such as population density,
comorbidity, and healthcare expenditures, which may be correlated with the case fatality
rate of COVID-19. The exploratory data analysis reported the descriptive statistics of
each predictor and outcome. Multiple linear regression was conducted on two levels. The
first model included the whole dataset of 148 countries as full samples to assess the
association between predictors and case fatality rates of COVID-19. As for the second
level of subgroup analysis, the dataset was stratified by four income levels specified by
the World Bank. Based on the preliminary data, hospital beds per 1,000 population
negatively correlated to the case fatality rate of COVID-19. For this model, we conclude
that a 1% increase in the hospital beds per 1,000 population would yield a 0.00282%
decrease in the case fatality rate of COVID-19. Conversely, the percentage of the
population older than 65 is positively associated with the case fatality rate. Also, the
current health expenditure of GDP is positively related to the case fatality rate of
COVID-19. Within 47 high-income countries, hospital beds per 1,000 population
negatively correlated to the case fatality rate of COVID-19. For the second model, a 1%
increase in the hospital beds per 1,000 population yielded a 0.00754% decrease in the
case fatality rate of COVID-19. On the contrary, the percentage of the population older
than 65 was also positively associated with the case fatality rate. Finally, the Democracy
Index negatively correlated to the case fatality rate of COVID-19. However, the current
health expenditure of GDP did not reach a significant level among high-income countries
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as shown in Model 2. The findings of high-income countries analysis demonstrated a
negative association between democracy and health outcomes of COVID-19, which
coincides with previous studies on the relationship between democracy, maternal and
infant mortality rates, and HIV/AIDS prevalence.5,7,10
Chapter 4 investigated the information biases of cases and deaths of COVID-19 in
terms of the data collection problem. Our contribution to the literature is to use a
simulated graphical trajectory method to identify the biases in surveillance data. This
approach incorporates all sources of available data with heterogeneity but provides a
better summary of the development of an infectious disease. To sum up, regions and
countries beginning with high mortality rates from the COVID-19 epidemic will suffer a
long, painful period of the disease epidemic. Where the mortality rate is relatively high,
healthcare professionals should prepare for a longer period of fighting this pandemic.
Either ignorance or ineffective control measures may cause avoidable losses of lives.
Most importantly, the quality of data is key to case fatality rate estimation. Valid data
helps policymakers to make correct and timely critical decisions.

Implications for Policy
The previous literature we reviewed and the evidence we found across countries,
can inform both policymakers and practitioners about effective and promising measures
of containing emerging and re-emerging infectious diseases like COVID-19. From our
research findings, several implications for policy concerning COVID-19 are evident:

Orientation
Improving health outcomes is the ultimate orientation of public health policy and
should be a fundamental theme of policy. While the distribution of resources, welfare,
human right, economy, and re-election among stakeholders are exclusively important,
policymakers must keep in mind that the expected purpose of public health policy is for
the well-being of individuals, communities, and populations. In essence, policies should
be directed by principles that foster health.

Partnership
Policies at all levels must support partnerships within the network. Federal, state,
and local health departments can empower individuals and the community through clear
concepts, regulations, guidelines, and communication; support isolation and quarantine in
the community; provide up-to-date information and essential resources; and disseminate
effective practices at local, state and federal level. Building public health policies,
establishing technological information networks, and encouraging innovation are some of
the strategies that can facilitate the formation and collaboration of partnerships.
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Flexibility
Public health policies should be composed with an understanding of the contexts
where they are to be executed to allow for flexibility at the local sites. While federal,
state, and local policies must be written for a wide variety of contexts in which measures
are implemented, policy directives should be flexible enough to accommodate diversity
among the community, population, and countries. In other words, policies should not
cause additional obstacles to efforts aimed toward mitigating the pandemic.

Funding
Increasing investment in health expenditure is helpful but not the key to
improving health outcomes in the context of a pandemic. The health expenditure share of
the GDP needs rational adjustment while the public health sector requires more financial
support to activate. However, funding alone is not a powerful solution. A community
should have strategic planning, professional engagement, outreach, commitment, and
other non-financial resources, such as psychological resilience and self-efficacy, to be
successful in fighting against the pandemic.148 A key role for policy is the provision of
both financial and non-financial resources.

Implications for Practice
Our research findings have important implications for healthcare professionals
and policymakers endeavoring to contain the COVID-19 pandemic and improve the
health outcomes of the population. From this research and previous literature, we drew
the following implications for practice.
We offer recommendations for practitioners in the following section as to how a
democratic country as a whole might improve its responses to the health crisis. The first
issue that needs to be reconsidered is the efficiency of the government response. Our
findings show that the population density is not statistically related to the case fatality
rate of COVID-19 in 148 countries. Therefore, governments in democratic countries must
engage in legitimation and cannot rely on self-isolation as in authoritarian countries
where citizens would follow the restrictive measures. This established constriction of
democracies has triggered many challenges and disadvantages in speedily responding to
an emergency. However, this disadvantage should not be treated as a good reason for
slow action because, in response to a pandemic, democratic governments should have the
capacity to announce a state of emergency and even require public and private resources
to respond quickly. When a democratic country takes over civil rights and private
resources and restricts citizens’ mobility, the government should have a rational
justification for the society, and it should also compensate attacked populations during or
after the pandemic. Nevertheless, it is more difficult for the government to convince
citizens to take action quickly during the outbreak of a communicable disease because it
is often difficult to foresee the severe consequences of an epidemic. Despite statistics
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with biases, narrow-mindedness and personal interests, the slow and incorrect decisions
of governments, will bring catastrophe to the whole country. The slow response of
governments in Italy, India, and the United States to the pandemic has already had
tremendous costs for their countries and the world.149,150
Second, this worldwide health crisis suggests the vulnerability of society in
countries. We should reconsider how to protect our lives from dictatorships while
achieving the goal of pandemic mitigation. In essence, democratic countries have learned
a good lesson from COVID-19. The aging population and citizens with comorbidities are
high-risk populations who should have the privilege of receiving healthcare services and
necessary support, such as transportation, shelters, safe food supply, PPE, and social
workers’ assistance. We advocate for the detection of early symptoms in patients with
multiple chronic diseases, health information technology for remote monitoring of
quarantined or isolated patients, standardized measures in nursing homes, psychological
and emotional supports for severely ill patients, and protection for a normal lifestyle and
living environment of elderly patients.
Thirdly, being different from the previous international health in history,
humankind faces more challenges than before: First, citizens are uncertain of the
transmission of the pandemic. In democratic countries, governments are divided by
partisan supporters in responding to the disease. This upsurges the trouble of executing
any national public health policies. Secondly, the pandemic is also an economic crisis.
Unlike before, this crisis is synchronized in both supply and demand markets. These
characteristics interfere with the accountability of existing policy funding instruments and
will also expand the longstanding adverse effects of the policies. Finally, the pandemic is
also a showdown of the two fundamentally different political and economic systems.
Ultimately, the triple crises lead to the most challenging crisis of all: The lack of world
leadership among the democracies to formulate and execute concerted efforts to deal with
the crises unseen.151

Implications for Future Research
The associations we investigate here are quickly evolving and it is reasonable to
assume variations to these patterns in the future. For authoritarian countries, the
economic recession may enhance broader business lockdowns and social distancing
policies, and the healthcare capacity needed for massive testing and contact tracing may
not be taken. Immediate responses by countries in such contexts, such as shutting down
international airports and facilitating mobile testing sites in trucks, seem to have been
useful in slowing the transmission of COVID-19, but even comparatively inexpensive
measures may not be accessible for mitigating COVID-19 if the disease remains
dominant. In this way, we may observe that government function, political accountability, and social interconnection in later phases of a pandemic would make differences
from those of earlier phases. To examine these longer-term associations, we recommend
iterating the analyses offered here, using the same variables. We suggest the primary
outcomes for future work will be deaths per capita due to COVID-19 and excess deaths.
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The data on excess deaths relies to some degree on Electronic Medical Record (EMR) or
Electronic Health Records (EHR) and statistics, which will vary in quality across
countries with superior surveillance systems in high-income countries and inferior
reporting systems in low-income countries.152 Although the Democracy Indices positively
associated with case fatality rates of COVID-19 in high-income counties, the health
inequity and underserved population in low-income countries need more investigations to
explore the predictors of health outcomes related to epidemics and pandemics.
We look forward to future research that will implement apples-to-apples
comparison. That is, simply conducting studies of X disease or Y risk factors in various
countries instead of using a truly international comparative approach is problematic. Very
limited research has taken place in the context of global health crises that could overcome
these barriers. Current research has some limitations and difficulties, e.g., the sensitivity
of the results to time and outcomes. Besides, statistical analysis results depended on the
measurement of association proposed in the comparative studies.
Future work should innovate in measuring predictors and outcomes in poor
resource settings because existing datasets have relied on biased death certificates and
health survey data collected during the pandemic.153,154 In some cases, the statistical
analysis will be limited to assessing conditional correlations and testing whether these
differ from zero. We encourage researchers to conduct further analysis by integrating a
broader knowledge base within this field. For example, researchers can design
investigation instruments such as questionnaires and surveys that will be distributed to
regions or countries where they will be able to describe and report the data and suggest
supplementary tests.
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